Scope: Italy and the European Union, 2023–September 2026, with the United Kingdom, France and Germany incorporated where required for the European strategic assessment. The report examines the institutionalisation of anti-Israel pressure across universities, research policy, technology cooperation, investment and public discourse; the Ribolla/Shikun & Binui controversy; the measurable technological importance of Israel; and the consequences for Italy and Europe of nationality-based or indiscriminate disengagement.

---

Executive Summary / BLUF

The central judgment is that anti-Israel pressure in Italy has moved beyond protest against the policies of the Israeli government and entered parts of the institutional, academic and technological sphere. This is no longer hypothetical. Major Italian universities have formally suspended Israeli agreements, prohibited new institutional relations, urged suspension of the bilateral scientific agreement, or created political criteria conditioning cooperation with Israeli academia.

The University of Bologna resolved in September 2025 to discontinue formal relations and collaborations with Israeli universities, institutions and companies, subject to a limited exception for existing non-dual-use research. University of Bologna — Academic Senate motion on Israeli universities, companies and institutions, 23 September 2025

The University of Pisa suspended framework agreements with Reichman University and the Hebrew University of Jerusalem in July 2025 and explicitly described the measure as a political message directed at the Israeli government. University of Pisa — Suspension of agreements with Reichman University and Hebrew University, 24 July 2025

At Sapienza University of Rome, the Physics Department adopted a motion asking the Italian government to suspend the bilateral Italy–Israel Industrial, Scientific and Technological Cooperation Agreement and urging academics not to participate in future MAECI bilateral research calls while the stated conditions persisted. Sapienza University of Rome — Motion requesting suspension of Italy–Israel scientific cooperation, 20 June 2025

A Sapienza institutional commission subsequently proposed the temporary suspension of 25 agreements with Israeli academic institutions that did not explicitly condemn Israeli government actions in Gaza and oppose occupation policy. That proposal is analytically important because it moves beyond assessing an institution’s own conduct and introduces an affirmative political-position test as a condition for continued academic relations.

These developments coexist with a markedly different position at the level of the Italian state. Italy’s Ministry of Foreign Affairs continued to operate the bilateral scientific and technological framework with Israel, including a 2025 joint research call on sustainable technologies addressing climate-change challenges in the Mediterranean. Even more significantly, a new call for a joint Italy–Israel laboratory remained active until 20 July 2026. Italian Ministry of Foreign Affairs — Italy–Israel Industrial, Scientific and Technological Cooperation Agreement

The result is an increasingly visible strategic contradiction inside Italy: parts of the university system are moving toward institutional disengagement while the Italian state continues to recognise scientific cooperation with Israel as an instrument of national innovation policy.

At EU level, pressure has also migrated from political declarations into research policy. In July 2025 the European Commission proposed partially suspending Israel from activities financed by the European Innovation Council Accelerator. Crucially, however, the proposal did not constitute Israel’s exclusion from Horizon Europe as a whole. European Commission — COM(2025) 620, proposed partial suspension of Israel from EIC Accelerator activities, 28 July 2025

By 7 April 2026, the Commission confirmed that this partial-suspension proposal remained on the table but had not been converted into a general doctrine of Israeli exclusion. The Commission made an especially important legal distinction: Israeli beneficiaries cannot be considered in breach of Horizon Europe obligations simply because they are established in Israel; action must be based on the conduct of the beneficiary. European Commission answer E-004869/2025 — European Parliament, 7 April 2026

That distinction should be the organising principle for European policy.

The economic stakes are substantial. Israeli high technology generated NIS 352 billion in output in 2025, equal to 18.3% of Israeli GDP. High-tech exports reached approximately US$85 billion, representing 58% of all Israeli exports, while the sector employed around 400,000 people. Israel ranked as the world’s fourth-largest technology hub by capital raised and the largest outside the United States according to the Israel Innovation Authority’s 2026 report. Israel Innovation Authority — State of High-Tech 2026, published 31 May 2026

The implication for Italy is not that every Israeli technology is irreplaceable. That proposition would be analytically indefensible. The stronger and supportable judgment is that systematically excluding Israeli research institutions, startups and technology companies would voluntarily sever access to one of the most concentrated innovation ecosystems in the world, particularly in cybersecurity, artificial intelligence, semiconductors, defence-related technologies, medical technology, water systems, agritech, advanced sensors and climate technology.

At the same time, the rise in hostility surrounding Israel is occurring alongside a documented deterioration in the security environment for European Jews. The European Commission states that, since the 7 October 2023 Hamas attacks and the ensuing war, Europe has experienced levels of antisemitism “unprecedented since the founding of the European Union.” EU data cited by the Commission indicate that 96% of surveyed Jewish respondents had encountered antisemitism online or offline, eight in ten believed antisemitism had increased, and 76% avoided displaying objects that would identify them publicly as Jewish. European Commission — Combating antisemitism

This does not make criticism of Israeli policy antisemitic. It establishes instead why European governments cannot treat the boundary between legitimate criticism, anti-Zionist mobilisation, nationality-based exclusion and antisemitic hostility as a secondary matter.

The strategic risk is therefore twofold: Europe can simultaneously lose access to Israeli technological capability and allow a political dispute with a government to migrate into institutional discrimination against Israeli academia, companies or individuals. Italy is one of the clearest laboratories of that tension.

Syria Between Turkish Dependence and Israeli Coercion

Europe is turning a political dispute with Israel into an innovation problem

Italy and Europe are drifting toward a contradiction that is becoming economically expensive: universities and EU institutions are tightening political conditions on cooperation with Israel while governments and companies continue to depend on Israeli capabilities in cybersecurity, artificial intelligence, semiconductors, defence, water technology, health and mobility. By 2025 Israeli high-tech generated NIS 352 billion, equal to 18.3% of GDP, and produced roughly US$85 billion of exports, while Israeli entities had already secured about €831 million across 747 Horizon Europe grants by April 2025. The issue is therefore no longer whether Europe should criticise Israeli policy; it is whether political pressure should be allowed to fragment scientific and industrial networks that European competitiveness policy is simultaneously trying to strengthen. Italy now sits at the centre of that contradiction.

Universities are moving faster than the Italian state

On 23 September 2025, the University of Bologna decided to discontinue formal relations and collaborations with Israeli universities, institutions and companies, subject to a limited exception for existing non-dual-use research, while the University of Pisa had already suspended framework agreements with Reichman University and the Hebrew University of Jerusalem on 24 July 2025, explicitly presenting the decision as a political message to the Israeli government; the distinction matters because these measures no longer concern only the conduct of a specific project but use academic cooperation itself as an instrument of foreign-policy pressure.

At Sapienza University of Rome, the Physics Department voted 97 to 27, with seven abstentions, in June 2025 for a motion seeking suspension of the Italy–Israel Agreement on Industrial, Scientific and Technological Cooperation, while other university bodies examined the suspension of as many as 25 agreements with Israeli academic institutions and central governance later introduced tighter dual-use and human-rights screening for extra-EU cooperation, including specific provisions covering Israel and Russia; these are different instruments, but together they show how political pressure can migrate from protest into procurement, research approval, consortium formation and institutional eligibility.

The Italian government has not followed the same course. The Ministry of Foreign Affairs and International Cooperation kept the bilateral scientific framework active through 2025 and, in 2026, issued a call for two joint Italy–Israel laboratories under the same agreement, with a deadline of 20 July 2026. The result is a fragmented national position in which the state continues to finance cooperation that sections of the university system are attempting to restrict.

The numbers explain why this is not a symbolic dispute

According to the Israel Innovation Authority, Israeli high-tech output reached NIS 352 billion in 2025, rising 8.2% in real terms, accounting for 18.3% of GDP and approximately half of total Israeli economic growth, while high-tech exports reached about US$85 billion, equivalent to 58% of national exports and roughly 79% of sector output; these figures do not make Israel indispensable to Europe, but they do establish that Europe is debating disengagement from an economy in which technology concentration is exceptionally high.

The same ecosystem contained roughly 1,500 deep-tech companies, which had raised more than US$28 billion between 2019 and 2025, while artificial intelligence alone accounted for 32.5% of Israeli technology investment in 2025 and more than 2,000 AI companies were operating across the market; semiconductor companies represented 9.8% of deep-tech capital raised, Israeli cybersecurity firms captured more than 20% of global deep-tech cyber investment, and medical-device and AgriFood companies each held roughly 9–10% of global deep-tech investment in their respective categories.

Those figures matter because Europe’s weakness is not a lack of scientific capacity but insufficient conversion of science into scalable technology, and the European Commission’s June 2025 analysis on fragmented EU innovation hubs concluded that Europe is materially less interconnected than the United States in complex technologies including AI, biotechnology and quantum computing; reducing one of the external networks already integrated into European research therefore compounds a problem Brussels itself has formally identified.

Europe still buys what parts of its institutions want to isolate

The clearest contradiction appears in defence, where political pressure against Israel has intensified while European governments continue purchasing Israeli systems at scale. Israel’s Ministry of Defense reported US$19.2 billion of defence exports in 2025, nearly 30% above 2024, with Europe accounting for 36% of the total and Germany’s expanded Arrow 3 acquisition contributing materially to the record year.

The composition of those exports shows why procurement behaviour diverges from political rhetoric: missiles and air-defence systems accounted for 29% of 2025 agreements, observation and optronics for 22%, radar and electronic warfare for 11%, manned aircraft and avionics for another 11%, while command-and-control systems, drones, cyber, satellites and maritime platforms made up much of the remainder; defence ministries therefore face an immediate operational calculation that universities do not, because replacing a research agreement carries diffuse costs while replacing an air-defence, radar or electronic-warfare capability requires a credible system, delivery schedule and budget.

Germany has drawn that distinction explicitly. On 1 September 2025, the Federal Foreign Office stated that sanctioning scientific cooperation under Horizon Europe was not considered a sensible instrument because it would damage collaboration between German and Israeli researchers, and Chancellor Friedrich Merz subsequently argued that Germany had no interest in damaging economic or scientific cooperation with Israel and wanted instead to deepen it; Berlin’s position demonstrates that criticism of Israeli policy and preservation of scientific links are not institutionally incompatible.

Italy has spent years building the very network now under pressure

Italy’s exposure is not limited to trade because the bilateral model was designed around complementarity: Israeli startups and research centres provide early-stage technologies, software, sensors and deep-tech experimentation, while Italian companies provide manufacturing, industrial validation, certification, supply chains and access to European markets. The Italian Embassy in Tel Aviv documented cooperation involving Stellantis/FCA Italy, Enel, STMicroelectronics, Sparkle, Snam and Adler, including formal agreements with the Israel Innovation Authority and innovation presences created specifically to identify Israeli technologies before commercial maturity.

The agreement between Stellantis and the Israel Innovation Authority illustrates the mechanism clearly: Israeli startups were to be identified according to Stellantis’s industrial requirements, while FCA Italy would support successful companies in scaling, integrating with R&D networks and accessing global commercial infrastructure. The value therefore lies upstream of trade statistics, because Italy gains technological optionality before products become commodities and before foreign competitors have captured the same intellectual property.

The same structure extends across sectors already identified by Italian economic diplomacy as priorities: ICT, artificial intelligence and cybersecurity; energy transition and water technologies; aerospace and defence; infrastructure and sustainable mobility; pharmaceuticals and biotechnology. A political decision that weakens these channels does not merely reduce cooperation with Israel; it reduces the number of innovation sources available to Italian firms in exactly the sectors in which Rome is trying to raise productivity and technological autonomy.

Brussels is testing pressure through innovation policy

On 28 July 2025, the European Commission proposed COM(2025) 620, which would partially suspend Israel from new activities funded through the European Innovation Council Accelerator, the part of Horizon Europe designed to support high-risk, high-impact technologies approaching commercial deployment. The proposal stopped short of excluding Israel from Horizon Europe as a whole, but the choice of instrument was significant because it targeted the part of the European system closest to deep-tech commercialisation.

By 7 April 2026, the Commission confirmed that the proposal remained on the table while preserving an important legal boundary: an Israeli beneficiary could not be considered in breach of Horizon Europe obligations simply because it was established in Israel, and enforcement against an individual beneficiary had to depend on that beneficiary’s own conduct. This distinction is the core governance issue now facing Europe, because once restrictions move from documented conduct to nationality or institutional origin, foreign-policy pressure becomes collective economic attribution.

A second Commission proposal, COM(2025) 890 of 17 September 2025, moved further by contemplating suspension of specified trade-related provisions of the EU–Israel Association Agreement, including areas touching goods, establishment, services, procurement, competition and intellectual property; the procedure remained ongoing in the dossier, but the direction is clear: Europe has expanded the instruments through which political pressure can be transmitted from diplomacy into research, trade and commercial eligibility.

The real sovereignty test is whether Europe replaces capability or merely loses access

The European Commission’s 2025 Competitiveness Compass places closing the innovation gap and reducing excessive dependencies at the centre of European economic strategy, but those objectives are compatible only if restrictions are accompanied by domestic replacement capacity; where Europe excludes an external technology source without reproducing the capability at home, strategic autonomy does not increase, and dependence can simply shift toward larger US suppliers that acquire or commercialise the same Israeli-origin technologies.

Italy is particularly exposed to this asymmetry because the Ministry of Universities and Research announced more than €381 million in 2026 for research infrastructure, technology transfer, AI, high-performance computing, quantum technologies and advanced scientific capacity, while university-level restrictions were simultaneously making parts of the country’s international research network more politically conditional. Public investment in laboratories has less value if those laboratories are progressively disconnected from external ecosystems that provide specialist knowledge and early-stage technologies.

France and the United Kingdom illustrate why the European response remains divided. The French government continued operating the French-Israeli High Council for Scientific and Technological Research and Cooperation and in February 2026 opened a new call for the French co-chair, while the United Kingdom’s 2030 UK–Israel Bilateral Roadmap attributes approximately £1.2 billion of UK economic impact to more than 250 partnerships facilitated by the UK–Israel Tech Hub and maintains bilateral cooperation in AI, clean energy, health, water and space.

The next 12–24 months will decide whether fragmentation becomes structural

Between late 2026 and 2028, the decisive indicators will be operational rather than rhetorical: whether the Italy–Israel joint laboratories launched under the 2026 MAECI framework become active, whether Horizon restrictions expand beyond the EIC Accelerator, whether Italian universities replace nationality-based limitations with project-specific dual-use and human-rights screening, whether German and French cooperation remains intact, and whether major European companies continue locating R&D, venture-scouting and technology partnerships inside Israel.

If those links survive, Europe will retain the ability to criticise Israeli policy while treating technology and research through conduct-based rules; if they erode, the immediate cost will fall first on researchers, startups and industrial groups that lose partners and access, but the larger cost will eventually be borne by European taxpayers and companies through duplicated research, slower technology adoption, greater dependence on alternative foreign suppliers and weaker conversion of public R&D spending into industrial capability.

The risk is therefore not that Europe will become technologically backward within 24 months, nor that Israel can dictate European innovation policy, but that Europe will spend heavily to correct its innovation deficit while simultaneously narrowing one of the external networks that has been helping its companies, laboratories and governments acquire technologies they do not yet generate at equivalent scale themselves.

The Agent Lifecycle: Recruitment – Control – Exit Risk – Israel, Russia, China, the United States, United Kingdom, France, Germany and Italy

---

Navigational Index

Pillar I — From Gaza Protest to Institutional Disengagement

Italian universities, research institutions, EU initiatives, boycott mechanisms, political conditionality and the transition from government-specific criticism to measures affecting Israeli institutions collectively.

Pillar II — Israel as a European Technology Node

Cybersecurity, AI, semiconductors, defence technology, water, agriculture, energy, health, mobility and the structure of Italy–Israel scientific and industrial cooperation.

Pillar III — Strategic Consequences for Italy and Europe

Innovation loss, research fragmentation, technology sovereignty, industrial competitiveness, discriminatory-risk thresholds, antisemitism, policy safeguards and the five-year outlook.

---

Master Abstract

An anti-Israel pressure architecture is becoming institutional

The European argument over Israel has changed character since October 2023. Initially concentrated around demonstrations, parliamentary debate and foreign-policy pressure concerning Gaza, it has increasingly entered universities, scientific cooperation programmes, investment decisions, procurement debates and technology partnerships.

Italy provides unusually clear evidence.

The University of Bologna’s September 2025 decision was not confined to a military programme or to an individual Israeli entity shown to have committed a specified violation. Its Senate called for the university to “discontinue all formal relations and collaborations with Israeli universities, institutions and companies”, except for existing projects that were not dual-use, and not to establish new ones.

Official University of Bologna resolution, 23 September 2025

That is institutionally different from withdrawing from a specified defence contract. Nationality and institutional location become material screening criteria.

Pisa adopted a narrower but still explicitly political action. Its governing bodies terminated two framework agreements with Reichman University and the Hebrew University of Jerusalem. The university itself stated that the measure represented a political message to the Government of Israel. At the same time, Rector Riccardo Zucchi stressed that Pisa continued collaborating with Israeli institutions in environmental sciences and neuroscience and rejected the idea that the measure constituted a blanket rejection of Israeli science.

University of Pisa official statement, 24 July 2025

The distinction matters: Italian academia is not uniform. Nevertheless, the direction of political pressure is observable.

At Sapienza, the process went further conceptually. The Physics Department approved by 97 votes to 27, with seven abstentions, a motion asking the Italian government to suspend the national bilateral scientific agreement and asking faculty not to participate in future MAECI cooperation calls.

Sapienza Physics Department motion, 20 June 2025

A separate Sapienza commission recommended temporarily suspending 25 agreements with Israeli academic institutions that did not explicitly condemn Israeli government action and oppose occupation policy.

This introduces an important governance question. Academic partners would no longer be evaluated only on scientific integrity, legal status, direct involvement in prohibited conduct, export-control risk or dual-use exposure. They would also be assessed according to whether they make the political declaration demanded by the European partner.

That is a material change from risk-based due diligence to political conditionality.

The state has not followed the universities into a comprehensive boycott

The most important corrective to any claim that “Italy has broken with Israel” is the conduct of the Italian government itself.

The Italy–Israel Industrial, Scientific and Technological Cooperation Agreement remains part of the MAECI scientific-diplomacy architecture. The Ministry’s 2025 monothematic call explicitly sought joint Israeli–Italian projects in:

“Sustainable technologies to tackle the challenges resulting from climate change in the Mediterranean region.”

Italian Ministry of Foreign Affairs — 2025 Italy–Israel joint research call

More importantly for the current 2026 cut-off, MAECI issued a call for proposals to establish a joint laboratory under the Italy–Israel industrial, scientific and technological cooperation agreement, with the call expiring on 20 July 2026.

Italian Ministry of Foreign Affairs — 2026 call for an Italy–Israel joint laboratory

This creates a policy divergence inside Italy.

At national level, scientific diplomacy still treats Israeli technological capability as a strategic asset worth integrating with Italian research.

At parts of the university level, political pressure is pushing towards suspension, non-participation or formal separation.

The contest is therefore not over whether anti-Israel disengagement exists. It demonstrably exists. The unresolved question is how far it will spread into state policy and the industrial system.

Israel – Intelligence Penetration: The Resistance to 2031

The EU is itself testing technological pressure against Israel

Brussels has also crossed from diplomatic criticism into proposed technology restrictions.

On 28 July 2025, the European Commission presented COM(2025) 620, proposing partial suspension of Israel’s participation agreement in Horizon Europe.

The restriction concerned participation by Israel-established entities in activities funded through the European Innovation Council Accelerator, a programme specifically designed to support high-potential innovative enterprises.

European Commission — Proposal COM(2025) 620, 28 July 2025

The choice of instrument deserves attention.

The EIC Accelerator is not symbolic diplomacy. It targets precisely the category in which Israel is unusually competitive: high-risk, high-impact technology companies capable of scaling disruptive innovation.

A restriction here therefore operates directly on the interface between geopolitics and technological competitiveness.

Nevertheless, Brussels has retained an essential legal safeguard.

In an official answer published on 7 April 2026, Commissioner Ekaterina Zaharieva stated on behalf of the Commission that Israeli beneficiaries cannot be considered in breach merely by being established in Israel and that enforcement must depend on the conduct of the individual beneficiary rather than the conduct of the Israeli state.

European Parliament — Commission answer E-004869/2025, 7 April 2026

That principle is strategically consequential.

If applied consistently, it prevents a foreign-policy disagreement from becoming collective institutional liability.

Israel is not a peripheral technology economy

The argument for maintaining technological relations with Israel does not require ideological sympathy.

It rests on industrial data.

According to the Israel Innovation Authority’s 2026 State of High-Tech Report, Israeli high-tech output reached:

• NIS 352 billion in 2025;
• 18.3% of total Israeli GDP;
• real output growth of 8.2% year-on-year;
• approximately US$85 billion in exports;
• 58% of all Israeli exports;
• approximately 400,000 employees, or 11.4% of total employment;
• almost US$15 billion in capital raised;
• approximately 775 newly established startups during 2025.

High-tech alone contributed approximately half of total Israeli GDP growth in 2025.

Israel Innovation Authority — State of High-Tech 2026: Macro, 31 May 2026

These numbers describe an economic structure with few equivalents among advanced economies.

They also explain why technological disengagement has asymmetric effects.

Israel would unquestionably suffer from restrictions on access to European markets, funding and research networks: exports account for approximately 79% of Israeli high-tech output.

But Europe also loses.

Israeli technological capabilities are embedded in international value chains, venture-capital networks, multinational R&D centres and specialised technology markets. Cutting cooperation does not recreate those capabilities domestically. It removes one source from Europe’s innovation network.

The relevant policy question is therefore not whether Israel is dependent on the outside world. It is.

The question is whether Europe benefits from making itself less connected to a technology ecosystem producing US$85 billion of annual high-tech exports and representing almost one fifth of the originating country’s GDP.

For an EU already concerned with technological sovereignty, weak venture scaling, dependence on US digital platforms, Asian semiconductor capacity and the commercialisation gap between European research and American capital markets, indiscriminate technological disengagement is difficult to reconcile with competitiveness policy.

The Italian strategic exposure

Italy’s technological relationship with Israel must be understood as an innovation network rather than a simple bilateral trade account.

The bilateral architecture has deliberately connected companies, universities, laboratories and technology agencies. The continuing MAECI programmes demonstrate that Italian policymakers historically viewed Israel not primarily as a commodity supplier but as a research and innovation partner.

This distinction matters because high-value technology cooperation produces effects not fully visible in conventional import statistics:

joint intellectual property;
startup scouting;
technology transfer;
industrial pilots;
venture participation;
cybersecurity solutions;
medical technologies;
advanced agriculture;
water-management technology;
sensors and electronics;
artificial intelligence applications;
dual-use innovation;
university-to-industry knowledge transfer.

Removing access to such networks has a cumulative rather than immediate cost.

Italy would not wake up technologically incapacitated the day after suspending cooperation.

The damage mechanism would instead operate through a gradual reduction in technology options, scientific contacts, startup access, intellectual-property exchange, co-development opportunities and competitive intelligence about fast-developing sectors.

Over five years, those losses can become substantially more important than the headline value of bilateral merchandise trade.

The Ribolla affair shows how the political test is expanding

The controversy surrounding the approximately 20 MW Ribolla agrivoltaic project in Tuscany illustrates the next phase of the debate.

The objection is no longer necessarily directed at the environmental characteristics of the Italian project itself.

It increasingly concerns the corporate ancestry and Israeli activities of the economic group above the project company.

The supplied documentation records that SPV Energy 3 sits within a corporate chain associated with Shikun & Binui Energy and that activists subsequently focused on the wider group’s activities involving settlements and Israeli military infrastructure.

The same material records that the Israeli group’s participation in Italian renewable-energy investment had not been concealed; its acquisition activity in Italy had previously been publicly announced.

This case is important not because scrutiny of corporate conduct is illegitimate. It is important because it reveals how the screening criterion can migrate:

from the Italian project’s conduct → to the parent company’s activities → to the parent’s Israeli defence relationships → to the nationality and political context of the investor itself.

These categories should not be collapsed.

Where a company is sanctioned, legally excluded, directly involved in unlawful activity relevant to the transaction, subject to export-control restrictions, or presents a defined national-security risk, scrutiny has an identifiable legal hook.

Where none of those conditions applies, an exclusion based primarily on nationality or on the political symbolism of the parent group’s activities becomes a substantially different policy instrument.

The Ribolla debate is therefore a test case for whether Italy moves toward conduct-based economic security screening or politically driven origin-based exclusion.

Academic boycotts are strategically more consequential than they appear

Universities are often treated as peripheral to industrial strategy.

In technology-intensive economies this is incorrect.

Israeli universities feed the country’s startup, cyber, defence, medical and advanced-science ecosystems. European cooperation with Israeli universities therefore connects directly to future industrial capability.

A university boycott operates upstream.

Its immediate effect may involve only an exchange programme or framework agreement. Its longer-term effect can include fewer joint publications, weaker researcher mobility, fewer patent collaborations, reduced exposure to startup formation and fewer relationships between laboratories and industry.

This is why the decisions taken by Bologna, Pisa and parts of Sapienza deserve attention beyond campus politics.

They can create institutional precedent.

Once political acceptability becomes a precondition for academic cooperation with Israeli institutions, the mechanism can spread from universities to:

research councils;
public procurement;
municipalities;
pension funds;
innovation agencies;
professional associations;
technology accelerators;
corporate ESG policies.

The issue then ceases to concern one bilateral agreement.

It becomes an ecosystem effect.

From criticism of Israel to differential treatment of Israeli institutions

European institutions themselves recognise that criticism of Israel and antisemitism are not synonymous.

That distinction must be preserved.

At the same time, the European Commission’s working framework explicitly identifies several patterns that can cross into antisemitism, including applying standards to Israel that are not demanded of comparable democratic states, holding Jews collectively responsible for Israeli state actions, or denying Jewish self-determination in antisemitic form.

European Commission — Combating antisemitism and IHRA working framework

This framework becomes relevant when institutional measures cease to examine individual conduct.

A requirement that an Israeli university explicitly condemn its government before academic cooperation is maintained is qualitatively different from refusing participation in a specifically identified military programme.

A prohibition on new relations with Israeli universities, institutions and companies as a class is qualitatively different from sanctions against a named entity.

Those distinctions should be central to any Italian governance framework.

The antisemitism environment has deteriorated sharply

The broader social environment cannot be separated completely from institutional pressure.

The European Commission currently states that antisemitism in Europe has reached levels unprecedented since the establishment of the European Union following the October 2023 terrorist attacks and subsequent war.

The Commission cites EU Agency for Fundamental Rights findings that:

Indicator	Recorded result
Jewish respondents encountering antisemitism online or offline	96%
Respondents saying antisemitism had increased	8 in 10
Respondents avoiding visible Jewish identifiers in public	76%

European Commission — Combating antisemitism, incorporating FRA survey findings

In February 2026, the Commission’s Directorate-General for Migration and Home Affairs stated that extremist groups from different ideological backgrounds were exploiting the post-7 October environment to incite antisemitic hatred online and offline and recorded increasing assaults, threats and abusive behaviour targeting Jews.

European Commission — Handbook on Online Antisemitism, 26 February 2026

The policy significance is not that pro-Palestinian advocacy should be categorised collectively as antisemitism.

It is that governments and universities need to recognise an observable environment in which legitimate political criticism, anti-Israel institutional activism and antisemitic mobilisation can overlap without being identical.

A serious governance system must distinguish them rather than pretending either that they are the same or that no interaction exists.

Europe is attempting two contradictory policies simultaneously

Europe currently wants greater:

technological sovereignty;
AI capability;
cyber resilience;
defence-industrial capacity;
deep-tech financing;
semiconductor competence;
medical innovation;
climate technology;
research commercialisation.

At the same time, segments of European politics and academia are advocating reduced interaction with one of the world’s densest concentrations of precisely those capabilities.

That is a strategic contradiction.

Israel’s economy is small compared with the EU’s aggregate economy. Its importance lies not in volume but in technology density.

This is why the question cannot be reduced to “Europe can buy elsewhere.”

Technologies are not interchangeable commodities.

An innovation ecosystem consists of people, patents, tacit knowledge, engineering experience, venture networks, early-stage companies and relationships accumulated over years.

Once those networks are broken for political reasons, recreating them with another partner carries time and opportunity costs.

Key Evidence Table

Indicator	Verified status/value	Reference date	Institutional significance	Official source
University of Bologna relations with Israeli institutions	Formal relations and new collaborations ordered discontinued, with limited existing-project exception	23 Sep 2025	Broad institutional disengagement	University of Bologna official resolution
University of Pisa	Agreements with Reichman and Hebrew University suspended	24 Jul 2025	Political pressure translated into institutional action	University of Pisa official statement
Sapienza Physics Department	97–27, 7 abstentions, for motion seeking suspension of bilateral scientific agreement	19–20 Jun 2025	Pressure aimed at state-level scientific cooperation	Sapienza official departmental motion
Sapienza proposed agreement suspension	25 Israeli academic agreements identified for temporary suspension under proposed political criterion	Jul 2025	Explicit political-position conditionality
Italian government bilateral R&D framework	Remains operative	2025–26	State policy has not adopted comprehensive academic boycott	MAECI Italy–Israel cooperation framework
Italy–Israel Joint Laboratory call	Call remained active to 20 Jul 2026	2026	Current evidence of continuing government-level scientific cooperation	MAECI joint laboratory call
EU action against Israeli high-tech participation	Partial EIC Accelerator suspension proposed	28 Jul 2025	Technology policy used as geopolitical pressure instrument	COM(2025) 620 — EUR-Lex
Commission legal safeguard	Israeli entities cannot be penalised merely for being Israeli	7 Apr 2026	Supports conduct-based rather than nationality-based screening	Commission answer E-004869/2025
Israeli high-tech output	NIS 352bn	2025	18.3% of GDP	Israel Innovation Authority — 2026 report
Israeli high-tech exports	US$85bn	2025	58% of total Israeli exports	same official report
High-tech workforce	~400,000	2025	11.4% of Israeli employment	same official report
High-tech capital raised	~US$15bn	2025	Israel ranked fourth globally by reported capital raising	Israel Innovation Authority — 2026 annual report release
Jews reporting antisemitism online/offline	96%	latest Commission-cited FRA survey	Material European social-security environment	European Commission — Combating antisemitism

Principal Assessment

The evidence supports five preliminary conclusions.

First, a measurable anti-Israel institutionalisation process is underway in segments of Italian academia. It is documented through adopted resolutions rather than inferred from demonstrations.

Second, some measures are extending beyond opposition to specific Israeli government decisions and toward the treatment of Israeli institutions as a category. Bologna’s prohibition on new formal relations and the Sapienza proposal tying cooperation to an explicit political declaration are the clearest examples.

Third, Italy has not adopted this approach at state level. The continuing MAECI scientific framework and the 2026 joint-laboratory initiative demonstrate that bilateral technological cooperation remains an instrument of official Italian policy.

Fourth, Brussels itself is under pressure to weaponise research and innovation access against Israel, but the Commission continues to recognise a fundamental legal boundary between Israeli nationality and the conduct of an individual beneficiary.

Fifth, broad technological decoupling would impose a real opportunity cost on Italy and Europe because Israel is not merely another medium-sized external economy. It is an unusually concentrated global technology hub whose 2025 high-tech output was NIS 352 billion, whose technology exports reached US$85 billion, and whose innovation networks occupy sectors Europe itself identifies as strategic.

The greatest policy error would therefore be to replace targeted legal accountability with collective institutional exclusion.

The former can be governed.

The latter progressively converts foreign-policy disagreement into technological self-denial.

Principal Gaps and Watch Indicators

The assessment would strengthen materially if the following developments occur:

• Italian government action on the bilateral scientific agreement. Suspension, amendment or explicit reaffirmation would establish whether university pressure is migrating into national policy.
• Additional university resolutions. A spread from Bologna, Pisa and Sapienza into a broader CRUI-level pattern would indicate systemic rather than local disengagement.
• Council decision on COM(2025) 620. Adoption, rejection or expansion of the Horizon Europe restriction would define whether Brussels remains targeted or shifts toward wider technological exclusion.
• Procurement and investment screening. The emergence of nationality- or Israel-specific tests in renewable energy, cybersecurity, infrastructure or public procurement would signal movement from academic boycotts into industrial policy.
• Corporate ESG policies. Exclusion of Israeli companies without individual conduct findings would demonstrate private-sector transmission of political pressure.
• Research-output effects. A measurable decline in Italy–Israel co-publications, joint patents, startup partnerships or researcher exchanges would convert political symbolism into quantifiable technological cost.
• Antisemitic incident trends. Further increases would raise the governance importance of distinguishing legitimate policy protest from hostile treatment of Jewish or Israeli individuals and institutions.

Net Assessment

Italy is not presently conducting a state boycott of Israel.

Something more fragmented—and potentially more consequential—is occurring.

Political pressure against Israel is diffusing downward and laterally through universities, departments, activist networks and institutional governance structures while the Italian government continues to cooperate technologically with Israel.

That produces an unstable two-track system.

One Italy is still financing and organising scientific cooperation with Israeli partners.

Another is debating whether those partners should be excluded unless they satisfy political conditions unrelated to their individual scientific conduct.

Europe is experiencing the same contradiction at a larger scale.

The continent wants strategic autonomy while contemplating restrictions on one of the world’s most productive deep-technology ecosystems.

It wants greater cyber capability while politically distancing itself from a leading cyber innovation hub.

It wants stronger artificial-intelligence and semiconductor capabilities while making research access part of its geopolitical sanctions debate.

It wants technological sovereignty while narrowing the number of advanced partners from which European firms and researchers can acquire knowledge.

None of this means that Israeli companies or institutions should be exempt from law, export controls, sanctions, procurement scrutiny, competition rules or human-rights due diligence.

It means the opposite: the rules should be applied to actual conduct with sufficient precision that nationality does not become a substitute for evidence.

That is the dividing line between governance and boycott.

The public record through September 2026 indicates that this dividing line is increasingly under pressure in Italy and across Europe.

Pillar I - From Gaza Protest to Institutional Disengagement

Principal judgment

The principal finding is that the Italian debate over Israel has moved materially beyond street protest, symbolic condemnation and criticism of the Netanyahu government and has entered the governance structures of universities, research institutions and European innovation policy. The shift is not uniform, centrally directed or legally equivalent across institutions, but the cumulative pattern is clear: between 2024 and 2026, a growing number of academic bodies moved from statements concerning Gaza to decisions affecting cooperation agreements, eligibility for new institutional partnerships, dual-use research, participation in bilateral programmes and, in some cases, relations with Israeli universities or companies as a category rather than only with specifically identified projects. This matters because the mechanism of pressure has changed. Demonstrations seek to influence policy from outside an institution; motions adopted by senates, boards and departments alter the institution's own rules. Once that transition occurs, political mobilisation begins to affect researcher access, joint laboratories, mobility, funding opportunities, knowledge networks and the reputational treatment of Israeli institutions themselves.

Italy illustrates the process especially clearly because it simultaneously contains some of the strongest university-level measures and a national government that has resisted a comprehensive academic boycott. The resulting system is therefore fragmented rather than coherent: the Ministry of Foreign Affairs has continued to administer the bilateral Italy–Israel industrial, scientific and technological cooperation framework, including new calls for joint research and laboratories, while individual universities have introduced measures ranging from enhanced due-diligence requirements to selective suspension and, in Bologna's case, a broad prohibition on new formal relations with Israeli universities, institutions and companies. The strategic significance lies precisely in this fragmentation. A formal national embargo is not required for technological disengagement to begin; if enough autonomous universities, departments, research centres, municipalities, pension funds and professional bodies introduce their own restrictions, the aggregate effect can approximate sectoral decoupling even while national treaties technically remain in force.

The evidence therefore supports describing the current phase as institutionalisation of anti-Israel pressure, provided that this formulation is used precisely. It does not mean that every criticism of Israel is anti-Israel, that every university measure is discriminatory, or that academic institutions have adopted identical policies. It means that pressure originally directed at Israeli government conduct has increasingly generated rules whose operative object is an Israeli university, Israeli company, Israeli research entity or Israel-based beneficiary, thereby shifting the dispute from foreign policy into the architecture governing scientific and economic cooperation.

From political mobilisation to institutional rule-making

The first phase after 7 October 2023 was dominated by demonstrations, petitions, occupations, academic assemblies and calls for ceasefire, divestment or suspension of relations. The more consequential phase began when these demands entered formal university governance. This distinction is essential because universities possess legal autonomy, control their international agreements, administer research funding, determine ethical-compliance procedures and influence access to European and national programmes. A motion approved by an academic senate therefore has an operational effect that a demonstration does not.

The Italian Minister for Universities and Research, Anna Maria Bernini, identified this risk early. In an April 2024 interview published on the Ministry's own website, she warned that an “emulative effect” was developing around calls to boycott Israel across universities, argued that such a boycott was the wrong choice, and explicitly urged a distinction between the Israeli government and the Israeli people. Her intervention is important not because ministerial statements bind autonomous universities—they do not—but because it demonstrates that the national government itself understood the emerging dynamic as something broader than ordinary campus protest. The Ministry's concern was precisely that measures adopted in one institution could become precedents for others, gradually normalising the treatment of Israeli academic cooperation as an exceptional political category.

That dynamic subsequently became observable. By mid-2025, measures had appeared at Pisa, Padua, Sapienza, Bologna, Milan and individual departments at Ca' Foscari, among others. They differed significantly in legal reach, and that difference should not be erased. Some institutions preserved existing research and applied conduct-based restrictions; some suspended only selected agreements; some introduced additional screening for dual-use research; others moved much further by stopping new institutional relations with Israeli entities generally. Taken together, however, they demonstrate a transition from political opposition to Israeli policy toward institutional mechanisms capable of constraining Israeli participation in academic and technological networks.

Bologna: the clearest move from targeted criticism to categorical disengagement

The University of Bologna provides the strongest documented example because its Academic Senate did not merely suspend a specified defence-related project, a particular university contract or an agreement shown to support military activity. On 23 September 2025, after what the university described as an extensive debate, the Senate resolved that the university should discontinue all formal relations and collaborations with Israeli universities, institutions and companies, subject to an exception for existing research projects that could not be classified as dual-use, and should not initiate new ones. The same resolution committed Bologna to intensify cooperation with other universities, CRUI and civil-society organisations supporting justice, peace, reconciliation and Palestinian educational reconstruction.
University of Bologna — Academic Senate motion on relations with Israeli universities, institutions and companies, 23 September 2025

The governance significance of this measure is considerable. The operative category is not confined to a list of sanctioned entities, companies directly involved in prohibited military activities or individual research programmes presenting an identified security or human-rights risk. Instead, the resolution applies prospectively to Israeli universities, institutions and companies as such, while grandfathering only a subset of existing non-dual-use research. That structure makes Bologna analytically different from a conventional compliance framework, because compliance normally asks what the particular project, partner or technology does; the Bologna measure begins with the nationality or institutional location of the prospective partner and then establishes a general restriction.

This does not mean the resolution lacks an articulated ethical rationale. The university explicitly connected the decision to peace, human rights and the war in Gaza. The point for institutional analysis is different: a normative objection to state conduct was translated into a broad rule governing relationships with entities that are legally distinct from that state. Once such a principle is accepted, the burden of differentiation shifts. Instead of excluding only an entity whose conduct has been individually established, the institution suspends the category and then carves out exceptions. In governance terms, this is the precise threshold at which foreign-policy criticism begins to generate a form of academic disengagement with potentially systemic effects.

Bologna's reference to cooperation “within CRUI” is also relevant. The Conference of Italian University Rectors is not a ministry and cannot impose binding foreign policy, but it provides a coordination environment through which university-level norms can diffuse. The Bologna text therefore did not conceive the measure purely as an internal matter. It explicitly situated it within a wider network of Italian universities and civil society, creating the possibility that a policy initially adopted by one institution could become a model for others. That diffusion mechanism is more significant over time than the immediate termination of any single agreement.

Pisa: selective suspension used explicitly as political signalling

The University of Pisa adopted a narrower approach, but its official reasoning demonstrates how academic cooperation was being used deliberately as an instrument of foreign-policy signalling. On 24 July 2025, its Board of Directors suspended two framework agreements, one with Reichman University and one with the Hebrew University of Jerusalem, following an Academic Senate resolution of 11 July. The university explicitly described the measure as an exceptional response to the humanitarian situation in Gaza and stated that it was intended as a political message to the Government of Israel. At the same time, Rector Riccardo Zucchi emphasised that Pisa continued collaborating with Israeli institutions in fields including environmental science and neuroscience and rejected the interpretation that the decision represented a blanket rejection of Israeli science.
University of Pisa — Suspension of framework agreements with Reichman University and Hebrew University, 24 July 2025

Pisa is important precisely because it lies between ordinary ethical review and full institutional boycott. The university did not prohibit every Israeli partnership. It selected two high-profile relationships and used their suspension symbolically to communicate political pressure to a foreign government. The mechanism therefore rests on the representative value of academic institutions: because Israeli universities are internationally visible and linked to the state's broader scientific ecosystem, withdrawing cooperation from them creates diplomatic and reputational pressure even when those institutions are not themselves the formal addressees of the political dispute.

This creates a governance problem that will recur throughout the European debate. If an academic agreement is suspended because its own research content is dual-use, legally problematic or directly implicated in military activity, the causal chain between the identified risk and the measure is comparatively clear. If the agreement is suspended because terminating it will send a message to the Israeli government, then the university partner becomes an instrument for applying pressure to an actor distinct from itself. Pisa acknowledged that purpose openly. That transparency is preferable to disguising a political choice as technical compliance, but it also confirms that Italian academic cooperation was no longer being treated exclusively as a scientific matter.

The significance should not be overstated: Pisa's rector explicitly preserved relations in other fields and rejected wholesale disengagement. Yet that limitation does not diminish the underlying institutional development. A precedent had been established whereby the suspension of a scientific relationship could be justified primarily by the political signalling value of the suspension itself.

Sapienza: from departmental activism to university-wide compliance architecture

Sapienza University of Rome demonstrates a second route by which pressure can become institutionalised: not through a single blanket boycott resolution, but through an accumulation of department-level motions, demands for suspension of state agreements and increasingly restrictive university-wide compliance procedures.

On 19 June 2025, the Department of Physics approved a motion concerning Israeli government policy in Gaza and the suspension of the Italy–Israel Agreement on Industrial, Scientific and Technological Cooperation. The vote was numerically substantial: of 159 eligible members, 131 voted; 97 supported the motion, 27 opposed it and 7 abstained. The department did not merely criticise Israeli policy. It called for suspension of the bilateral scientific framework itself, the instrument through which Italian and Israeli authorities had for years financed collaborative R&D.
Sapienza Department of Physics — Motion on suspension of Italy–Israel scientific and technological cooperation, June 2025

That is strategically more significant than an individual agreement because the bilateral framework sits above single universities and projects. Suspending it would affect future collaboration across a broad range of institutions and technology sectors, irrespective of whether the specific partner in a future proposal had any relationship with the Israeli military or with the conduct criticised in Gaza. The department-level resolution therefore sought to move pressure upward from university politics into national scientific diplomacy.

Within Sapienza, additional faculties also pushed for suspension or non-renewal of agreements. The Faculty of Architecture formally called for pressure on the Academic Senate to suspend 25 agreements with Israeli universities and research bodies and to refrain from new agreements while the conditions it identified persisted. A commission document within the Faculty of Civil and Industrial Engineering similarly situated discussion of academic cooperation within a broader condemnation of Israeli military conduct and university policy toward Palestinian institutions.

By October 2025, Sapienza's central governance bodies had adopted a different but equally consequential instrument. The Academic Senate, Board of Directors and College of Department Directors unanimously tightened the university's guidelines on potentially dual-use research conducted with partners outside the European Union, introducing specific provisions for countries considered at human-rights risk, including Israel and Russia. The rules provided for designated departmental compliance officers and a more demanding review procedure that could result in rejection of research requests. The university explicitly stated that Israel was included because of the treatment of Palestinians in the occupied territories, military operations in Gaza and alleged violations of international humanitarian law.
Sapienza University of Rome — New guidelines for research with extra-EU countries at human-rights risk, 8 October 2025

This measure deserves differentiated treatment. It is not the same as Bologna's categorical cessation of formal relations. Sapienza framed its policy as enhanced ethical and dual-use compliance, and Israel was not the only country identified; Russia was specifically included as well. From a governance perspective, this is a more defensible model because the research activity itself remains subject to assessment rather than being automatically excluded solely on nationality. Nevertheless, the measure still demonstrates how Israel had moved into a special-risk category within university research administration. Political and humanitarian controversy had been converted into a formal compliance variable.

The distinction between the Physics Department's demand to suspend the bilateral agreement and the central university's dual-use screening framework is therefore crucial. One seeks broad political interruption of a national cooperation mechanism; the other strengthens project-level oversight. Both arose from the same political environment, but they represent different stages on the spectrum between legitimate risk management and institutional disengagement.

Padua: the conditional model

The University of Padua adopted yet another model. On 1 July 2025, its Academic Senate unanimously approved a motion that condemned Israeli conduct in Gaza, supported Palestinian self-determination and recognition of a Palestinian state, and committed the university to promote a shared position through CRUI, the Ministry of Universities and Research and other national and international forums. At the same time, Padua explicitly reaffirmed that its existing agreements with Israeli universities and ongoing academic projects had teaching and research purposes consistent with its statute and research-integrity code. It therefore did not terminate all existing relations. Instead, it undertook not to enter into new agreements, or renew existing ones, with Israeli institutions and bodies deemed to contribute to serious violations of international law or to maintenance of the occupation.
University of Padua — Academic Senate motion of 1 July 2025

This is analytically important because it demonstrates that academic institutions possess policy choices other than either unrestricted cooperation or blanket boycott. Padua preserved existing scientific relations while introducing conduct-based political conditionality for future agreements. The unresolved difficulty is implementation: once a university declares that it will not cooperate with institutions that “contribute” to violations or occupation, it must define the evidentiary threshold for contribution, establish who determines it, decide whether indirect institutional connections are sufficient, create review and appeal mechanisms and distinguish institutional responsibility from the political conduct of the state.

Without those safeguards, a conduct-based framework can gradually become origin-based in practice. If “contribution” is defined very broadly, nearly any Israeli institution with defence research, government funding, reserve-service links, public-sector collaboration or geographic connections to contested territories can be classified as implicated. The apparent precision of the standard would then conceal an expansive exclusionary effect. The policy therefore depends less on the rhetoric of the motion than on the evidentiary rules used in implementation.

Padua is consequently one of the most important cases to monitor because it sits directly on the boundary between targeted due diligence and wider political exclusion.

Milan: indirect implication becomes an operative criterion

The University of Milan's Academic Senate unanimously adopted a motion on 16 September 2025 that condemned Hamas's 7 October attack and demanded the release of hostages while also strongly criticising Israeli military conduct. The institution then moved from political language to an operational rule: under the conditions then prevailing, it stated that it would refrain from new agreements or renewals with universities, institutions or other actors directly or indirectly implicated in the violations it identified.
University of Milan — Academic Senate motion on Gaza, 16 September 2025

The phrase “directly or indirectly implicated” is analytically significant because indirect implication can become an extremely elastic category. In ordinary legal or compliance frameworks, indirect involvement normally requires a defined connection—ownership, financing, supply, facilitation, control, material support or another demonstrable mechanism. When the concept is incorporated into institutional ethics without a similarly precise test, decision-makers acquire wide discretion. An Israeli university might be considered indirectly implicated because it hosts defence research; because graduates or faculty serve in reserve forces; because it receives government research funding; because it operates programmes with defence companies; or because it has not publicly opposed government policy. These are not equivalent forms of involvement, yet an undefined indirect-implication standard can collapse them into one category.

Milan's policy therefore represents an important intermediate stage in the institutionalisation process. It is more targeted than Bologna because it does not formally prohibit relations with every Israeli institution, but potentially broader than a conventional legal-risk test because it allows action against entities whose involvement is indirect. Whether such a framework becomes discriminatory in practice depends on how consistently equivalent standards are applied to institutions from other countries involved in conflict, military research, contested territories or alleged human-rights abuses.

That issue—comparability of standards—is one of the central governance questions in the entire European debate. A rule does not become neutral merely because it is written in general ethical language. Neutrality ultimately depends on whether the same evidentiary threshold is applied across countries with comparable risk profiles.

Ca' Foscari: pressure diffuses below the level of central governance

The institutionalisation process does not occur only through university senates or boards. It can also develop at faculty and departmental level, creating a decentralised network of restrictions even when the central university has not adopted a comprehensive policy. At Ca' Foscari University of Venice, for example, the Department of Environmental Sciences, Informatics and Statistics approved a motion on 31 July 2025 committing itself not to establish cooperation agreements with Israeli universities or research bodies it considered implicated in the military campaign and inviting faculty members individually not to pursue research collaboration with such institutions while hostilities and the identified violations continued.
Ca' Foscari University of Venice — Departmental motion on Gaza, 31 July 2025

This type of measure may have less formal reach than an institution-wide ban, but it is potentially more difficult to monitor because it operates through hundreds of semi-autonomous academic units. If departments independently decline Israeli partnerships, discourage participation in joint calls, refuse visiting scholars, avoid co-supervision or decide not to join consortia containing Israeli partners, the cumulative reduction in collaboration can be substantial without ever appearing as a national or even university-level boycott.

The mechanism resembles distributed sanctions without a central sanctions authority. Each decision may be modest, voluntary and justified as ethical autonomy; taken together, they alter the probability that Israeli researchers and institutions can participate in European knowledge networks. This is particularly important in Horizon Europe, where consortia formation often occurs informally months before a proposal is submitted. A partner does not need to be formally prohibited by Brussels to become effectively excluded if coordinators judge its participation reputationally or politically costly.

The cumulative Italian pattern

The Italian university landscape therefore cannot be reduced to a single position. The available official record instead reveals at least four distinct policy models:

Institution / body	Measure	Operational logic	Degree of disengagement
University of Bologna	End formal relations and collaborations with Israeli universities, institutions and companies; no new ones, with limited exception for existing non-dual-use research	Category-based institutional disengagement	High
University of Pisa	Suspend two framework agreements while maintaining other Israeli research cooperation	Selective political signalling	Medium
Sapienza Physics Department	Seek suspension of Italy–Israel scientific cooperation agreement	Pressure on national bilateral framework	High if implemented nationally
Sapienza central governance	Enhanced dual-use/human-rights screening, with Israel and Russia specifically identified	Risk/compliance-based	Targeted
University of Padua	Preserve existing research but refuse new/renewed agreements with institutions judged implicated in serious violations	Conditional conduct-based screening	Medium
University of Milan	No new/renewed agreements with actors directly or indirectly implicated	Broad implication test	Medium to potentially high depending implementation
Ca' Foscari departmental level	No agreements or research collaboration with Israeli entities considered implicated in military campaign	Department-level selective exclusion	Targeted but decentralised

The significance of this table is not the number of universities alone. It is the diversity of institutional pathways. Once the same political objective can be pursued through senate resolutions, departmental motions, dual-use compliance, agreement non-renewal, ethical screening and informal consortium selection, disengagement becomes structurally resilient. Reversing one mechanism does not necessarily reverse the others.

The Italian state has resisted the logic of comprehensive academic separation

Against this university-level movement stands a materially different state policy. The Italian Ministry of Foreign Affairs continued to administer the Italy–Israel Agreement on Industrial, Scientific and Technological Cooperation, including a 2025 bilateral call for research projects focused on sustainable technologies to address climate-change challenges in the Mediterranean. The call explicitly provided for joint Italian–Israeli selection and public funding under the bilateral agreement.
Italian Ministry of Foreign Affairs — Italy–Israel Industrial, Scientific and Technological Cooperation Agreement

The continuity extended into 2026. MAECI published a call for the establishment of joint laboratories under the same bilateral framework, with a deadline of 20 July 2026. This is especially important because it demonstrates that, while university pressure was intensifying, the central government was still actively creating mechanisms for new structured scientific cooperation rather than merely allowing old agreements to expire.
Italian Ministry of Foreign Affairs — 2026 call for Italy–Israel joint laboratories

This creates a notable institutional contradiction. The national executive treats scientific cooperation with Israel as a continuing instrument of diplomacy, innovation and Mediterranean policy, while parts of the university system treat the same relationship as a vehicle through which political pressure should be applied.

The contradiction is not merely philosophical. Joint bilateral programmes need universities and research institutions to submit proposals, host researchers, form laboratories and execute projects. A state can formally maintain an agreement while its practical value declines if institutions become unwilling to participate. The effectiveness of Italian science diplomacy therefore depends increasingly on decisions taken autonomously below the state level.

The Italian government has also continued to pursue scientific diplomacy as a conflict-bridging instrument. In May 2026, the Ministry of Universities and Research announced Italy's entry into SESAME, the Middle Eastern synchrotron facility in Jordan, explicitly describing scientific collaboration as a bridge where political tensions make dialogue difficult. This is conceptually the opposite of the boycott model: instead of treating research cooperation as leverage to punish a state, it treats scientific institutions as channels worth preserving precisely when political relations deteriorate.

The European Union: pressure moves from rhetoric into innovation policy

The same institutional shift can be observed at EU level, where the debate moved from parliamentary condemnation to proposals capable of restricting Israeli access to research and commercialisation funding.

On 28 July 2025, the European Commission proposed COM(2025) 620, a Council decision that would partially suspend Israel's participation in Horizon Europe. The measure was carefully targeted: it would render legal entities established in Israel ineligible for new grant and investment support under the European Innovation Council Accelerator, while leaving existing EIC Accelerator agreements unaffected and avoiding suspension of Horizon Europe cooperation as a whole.
European Commission — COM(2025) 620, partial suspension of Israel's Horizon Europe association

The choice of the EIC Accelerator was strategically significant. This instrument operates at relatively high technology-readiness levels and provides grant and investment support to innovative SMEs and, exceptionally, small mid-cap firms with technologies approaching commercial deployment. The Commission itself emphasised that the programme supports breakthrough and disruptive technologies and that technologies funded at these readiness levels can reach the market in comparatively short time frames. The proposal therefore did not target peripheral cultural exchange; it targeted precisely the part of European research policy most closely connected to commercial deep-tech scale-up.

The legal rationale was Article 2 of the EU–Israel Association Agreement, which defines respect for human rights and democratic principles as an essential element of the relationship. The Commission argued that a partial suspension could be justified by what it assessed as a material breach of that essential element and presented the measure as proportionate because it stopped short of terminating overall research cooperation.

This is the point at which anti-Israel political pressure became a concrete European technology-policy instrument. The proposed restriction was not directed solely at an Israeli ministry, military body or settlement enterprise. Its eligibility rule was territorial and corporate: legal entities established in Israel would lose access to the EIC Accelerator if the suspension entered into effect. The proximate conduct justifying the measure was attributed to the state, while the immediate entities bearing the research-policy consequence would be private or institutional beneficiaries established in that state.

That difference is fundamental. It marks the transition from conduct-specific enforcement to state-level countermeasure implemented through restrictions on a broader population of entities.

Brussels nevertheless preserved an important legal boundary

The European Commission subsequently articulated a limitation that should be regarded as one of the most important safeguards in the entire dossier. In an answer issued on 7 April 2026, Commissioner Ekaterina Zaharieva confirmed that the partial-suspension proposal remained on the table because it had neither been withdrawn nor amended, but she also stated that Israeli beneficiaries could not be considered in breach of Horizon Europe grant obligations simply because they were established in Israel. Any action under the grant agreement, the Commission explained, had to be based on the conduct of the beneficiary rather than on the actions or behaviour of the Israeli state.
European Commission answer on Israeli participation in Horizon Europe, 7 April 2026

The answer went further by rejecting a direct analogy with Russia. The Commission noted that after Russia's invasion of Ukraine, targeted EU restrictive measures had been adopted under the Treaty on European Union and Treaty on the Functioning of the European Union, whereas there were no equivalent EU restrictive measures applying generally to Israeli entities. This distinction is legally and politically consequential because it prevents institutions from simply importing the post-2022 Russia template and applying it automatically to Israel.

As of the verified 2026 record, the procedure concerning COM(2025) 620 remained ongoing rather than adopted as a completed suspension.

The EU position is therefore internally dual. The Commission has asserted that state conduct can justify a partial suspension of association benefits affecting Israel-established entities as a class, while simultaneously insisting that individual Horizon beneficiaries cannot be sanctioned under grant-compliance rules merely because they are Israeli. The first is an intergovernmental countermeasure; the second is a beneficiary-level legal safeguard. Confusing these two levels would produce precisely the collective-attribution problem that parts of the European academic debate risk creating.

The pressure expanded beyond research policy into trade policy

The Horizon Europe proposal was not the endpoint. On 17 September 2025, the Commission proposed COM(2025) 890, which would suspend specified trade-related provisions of the EU–Israel Association Agreement, including provisions relating to the free movement of goods, establishment and services, public procurement, competition and intellectual-property treatment. The proposal was presented under the same Article 2 human-rights framework and would, if adopted, move political conditionality from research support into the broader architecture of EU–Israel commercial relations.
European Commission — COM(2025) 890, proposed suspension of trade-related provisions of the EU–Israel Association Agreement

As with the Horizon proposal, the distinction between proposal and enacted measure is essential. EUR-Lex still records procedure 2025/0890/NLE as ongoing, so it must not be presented as though preferential trade arrangements had already been fully suspended.

Nevertheless, the proposal demonstrates institutional escalation. The sequence is analytically clear: diplomatic criticism was followed by review of the Association Agreement; review was followed by a proposed restriction on high-technology innovation funding; that was followed by a proposal affecting trade, establishment, services, procurement, competition and intellectual-property provisions. Even where measures remained pending, the policy repertoire available for applying pressure to Israel had broadened substantially.

The European Parliament became an amplifier of institutional pressure

The European Parliament's September 2025 debate further expanded the range of options being demanded. Several motions proposed far-reaching measures, including termination of participation in Horizon Europe, suspension of EU programmes, restrictions on dual-use research and defence-related cooperation, and broader trade or military measures. Not every motion was adopted, and it would be incorrect to treat group resolutions as EU law. Their significance lies instead in demonstrating the direction and intensity of parliamentary pressure.

The text actually adopted on 11 September 2025 acknowledged the Hamas attack of 7 October, demanded the release of hostages, addressed the humanitarian situation in Gaza and expressed concern about attacks on Israeli citizens and Jews in Europe amid rising antisemitism.
European Parliament — Resolution of 11 September 2025 on Gaza

This dual framing is important because it shows that European institutional criticism of Israel was not formally equivalent to hostility toward Israelis or Jews. Yet within the same political environment, parliamentary groups were pressing for measures capable of affecting research, trade and technology relations. The result was an increasingly politicised operating environment for universities and companies, even before every proposal became binding law.

For research managers and corporate decision-makers, political uncertainty itself has effects. Institutions forming multi-year consortia must consider whether an Israeli partner will remain eligible, whether a future Council decision will alter funding conditions, whether university boards will approve the partnership, and whether activist campaigns will create reputational costs. As a result, formal exclusion is not required for a chilling effect to emerge.

Boycott mechanisms operate through more than formal prohibitions

The practical architecture of disengagement is therefore broader than official suspension. It can work through four distinct channels operating simultaneously.

The first is formal institutional exclusion, as in Bologna, where new relations with Israeli universities, institutions and companies are prohibited by university policy.

The second is conditional non-renewal, as in Padua and Milan, where cooperation depends on an institutional judgment concerning implication in serious violations or occupation.

The third is compliance intensification, as at Sapienza, where Israel enters a designated risk category and research involving potentially dual-use subjects is subjected to more stringent review.

The fourth is informal anticipatory avoidance, which is harder to quantify but logically follows from the first three: investigators or consortium coordinators can decide not to invite an Israeli partner because they expect internal approval problems, activist opposition, funding uncertainty or political controversy.

The fourth mechanism is potentially the most consequential over time because it leaves the weakest documentary trace. A rejected agreement produces a resolution; a partnership never proposed produces no formal record. If political risk systematically changes who is invited into research consortia, official statistics may show declining cooperation without identifying the decisions that caused it.

This is why counting formal boycotts alone understates the phenomenon.

Political conditionality is moving from conduct to declaration

An additional development is the emergence of what can be described as political-position conditionality: collaboration becomes linked not only to what an Israeli institution does, but to whether it publicly takes a position deemed acceptable by the European partner.

This is analytically distinct from human-rights due diligence. Due diligence examines conduct, financing, ownership, contractual relationships, technology use and legal exposure. Political-position conditionality evaluates whether an institution has condemned, endorsed or remained silent regarding government policy.

The Sapienza debate over suspending agreements with Israeli institutions that had not taken sufficiently explicit positions is illustrative of this risk. Departmental and faculty proposals sought to make institutional posture toward the war relevant to continued cooperation.

If widely adopted, such a standard would transform academic cooperation into a form of political certification. An Israeli university would no longer need only to demonstrate scientific merit, compliance with export controls and absence of prohibited conduct; it might effectively need to prove political distance from its government.

That would be an unusually demanding standard by comparison with normal European academic relations with universities in states involved in military operations, repression, territorial disputes or human-rights controversies. A government-level review would therefore need to ask whether equivalent political-declaration requirements are imposed systematically on institutions from other jurisdictions. If not, the system risks developing a double standard even when its stated purpose is human-rights protection.

The Russia analogy is legally weak and strategically misleading

Some of the political argument for academic disengagement relies implicitly or explicitly on the precedent created after Russia's February 2022 invasion of Ukraine. The comparison has intuitive political force because European research institutions rapidly severed numerous Russian state-level relationships, but the Commission's April 2026 answer makes clear why the analogy cannot simply be transplanted.

Russia is subject to a large body of EU restrictive measures adopted under the Union's sanctions authorities. Israel, as the Commission noted, was not subject to equivalent broad restrictive measures applying to Israeli entities generally.

The consequence is straightforward: universities cannot assume that what became legally or politically standard for Russian institutions automatically applies to Israeli institutions. Where EU restrictive measures exist, compliance follows from binding law. Where they do not, a university introducing a nationality-based exclusion is making an autonomous political-governance choice rather than simply implementing sanctions.

That distinction is essential for senior government readers because the two actions have entirely different legal provenance.

The paradox at the centre of Italian policy

Italy is simultaneously investing heavily in research, technology transfer, artificial intelligence, quantum technologies and advanced scientific infrastructure while parts of its university system are narrowing collaboration with one of Europe's most technologically intensive external partners. In June 2026, the Ministry for Universities and Research and the Ministry of Enterprises and Made in Italy adopted a strategic framework for 2026–2028 explicitly aimed at strengthening the connection between research and industry, increasing technology transfer and improving the national innovation ecosystem.

The same month, MUR announced more than €381 million for research infrastructure, high-level scientific talent, technology transfer, quantum technologies, high-performance computing and artificial intelligence, explicitly presenting these investments as instruments for Italian and European technological autonomy.

Against that national objective, indiscriminate reduction of external research networks creates an obvious policy tension. Technological sovereignty does not mean scientific autarky. An advanced economy strengthens sovereignty by maintaining diversified access to multiple innovation centres while protecting critical technologies, not by voluntarily shrinking the number of high-capability ecosystems with which its universities can cooperate.

The anti-Israel pressure inside academia therefore has consequences beyond Middle East policy. It intersects directly with Italy's ability to acquire knowledge, form consortia, access startups, conduct dual-use research and participate in global technology networks.

Why the institutional threshold matters

The central analytical concern is not that universities express moral judgments. European universities routinely adopt positions on war, discrimination, academic freedom and human rights. The threshold becomes strategically significant when three conditions occur together: the institution moves from speech to restrictions; the restriction is applied to a broad class of entities rather than to individually demonstrated misconduct; and the evidentiary standard becomes political affiliation, geographic origin or insufficient public opposition to a government.

When those three conditions combine, a foreign-policy dispute begins to reshape the architecture through which knowledge is exchanged.

Bologna crosses closest to that threshold because nationality and institutional location are explicit elements of the restriction. Pisa remains more selective. Padua and Milan rely on involvement criteria whose ultimate impact depends on implementation. Sapienza's central governance has chosen a risk-based framework, but internal constituencies continue to press for broader suspension. Ca' Foscari shows that decentralised departments can act even when central policy is more cautious.

The Italian case is therefore not one story but a continuum.

The strategic trend lies in the direction of travel.

Key judgments

The Italian academic system has moved measurably from public condemnation of Israeli government policy toward formal institutional mechanisms that can reduce scientific cooperation with Israeli universities, research organisations and companies. The strongest example is Bologna's September 2025 decision to discontinue formal relations and not initiate new ones with Israeli universities, institutions and companies, while other universities have adopted narrower but still operational restrictions based on selected agreements, political signalling, dual-use risk, human-rights criteria or direct and indirect implication.

The process is decentralised and therefore potentially more durable than a single national political decision. University autonomy allows different institutions and even individual departments to adopt separate restrictions, meaning that cooperation can decline progressively without a formal state embargo.

Italy's national government has not adopted comprehensive scientific disengagement. MAECI continued bilateral Italy–Israel research calls through 2025 and issued joint-laboratory calls extending into July 2026, demonstrating continuing official commitment to bilateral scientific cooperation.

At EU level, the Commission transformed political pressure into a concrete innovation-policy proposal through COM(2025) 620, targeting Israel-established entities participating in future EIC Accelerator calls, but the measure remained an ongoing proposal in the verified 2026 record rather than a completed general suspension of Horizon Europe.

The European Commission has nevertheless preserved a critical legal safeguard by stating that individual Israeli Horizon beneficiaries cannot be treated as non-compliant simply because they are established in Israel and that beneficiary-level enforcement must be based on their own conduct rather than the conduct of the State of Israel.

The principal medium-term risk is therefore not a single dramatic rupture but cumulative network erosion: fewer agreements, fewer renewals, reduced researcher mobility, less willingness to invite Israeli partners into consortia, more demanding compliance screening and an expanding perception that cooperation with Israeli institutions carries unusual political and reputational costs.

What would change the assessment

The assessment would strengthen substantially toward a finding of systemic academic disengagement if CRUI, MUR or a large majority of major Italian universities adopted a common presumption against new Israeli partnerships; if the bilateral Italy–Israel scientific agreement were formally suspended; if Horizon Europe restrictions were broadened beyond the EIC Accelerator into general Israeli participation; or if national procurement, research-funding or mobility programmes began applying Israel-specific exclusions unrelated to individual conduct.

Conversely, the assessment would weaken if major universities replaced nationality- or institution-based restrictions with uniform, country-neutral compliance tests; if cooperation resumed once specific legal or humanitarian conditions were satisfied; if new bilateral joint laboratories under the MAECI agreement became operational at scale; or if university governance explicitly reaffirmed that individual Israeli academics and institutions would be assessed under the same standards applied to equivalent partners from other jurisdictions.

Open official record

The most important unresolved evidence concerns implementation rather than rhetoric. Public university resolutions establish policy intent, but comprehensive data are still needed on the actual number and value of Israeli agreements terminated, frozen, non-renewed or abandoned; the number of joint Horizon Europe proposals involving Italian and Israeli partners before and after 2024–2025; the effect on researcher mobility and joint publications; the precise criteria used by universities to determine “direct” or “indirect” implication; the treatment of comparable universities from other conflict-affected states; and the final disposition of the Commission's Horizon Europe and trade-suspension proposals. Without those data, the existence of institutional pressure is established, but its full quantitative impact on Italian scientific output and technology transfer cannot yet be measured with government-grade precision.

Pillar II — Israel as a European Technology Node

Principal judgment — Israel should be understood as an innovation network embedded in Europe, not as a conventional external supplier

Israel's technological significance for Europe, and particularly for Italy, cannot be measured adequately through bilateral merchandise trade, the number of Israeli companies physically operating in Europe, or the value of individual government research programmes, because the relationship functions increasingly as an interconnected innovation architecture in which Israeli research institutes, startups, scale-ups, multinational research centres, venture investors and specialised technology companies supply knowledge, intellectual property, engineering solutions and entrepreneurial experimentation to European industrial groups that possess greater manufacturing capacity, larger domestic markets and deeper integration into global production chains; viewed through this lens, Israel is not merely another non-European commercial partner but one of the external technological nodes through which European companies gain early access to innovation in cybersecurity, artificial intelligence, semiconductor design, advanced sensing, defence electronics, medical technology, water management, precision agriculture, climate technology, sustainable mobility and other sectors in which the difference between possessing an emerging capability at an early stage and purchasing it only after commercial maturation can translate into years of competitive advantage.

The scale of the Israeli ecosystem explains why political attempts to reduce scientific and industrial cooperation cannot be treated as costless acts of diplomatic signalling, because according to the Israel Innovation Authority's State of High-Tech 2026, Israeli high-tech output reached NIS 352 billion in 2025, rising by 8.2% in real terms, representing 18.3% of Israeli GDP and accounting for approximately half of total Israeli economic growth during the year, while high-tech exports reached approximately US$85 billion, equal to about 58% of Israel's total exports and roughly 79% of the sector's output, figures that show an economy in which technology is not a peripheral specialisation but the central transmission mechanism between domestic research capacity and global markets.
Israel Innovation Authority — State of High-Tech 2026: Macro

The same official report shows that Israel's technological structure is also becoming more diversified than the familiar image of a predominantly software-based "Startup Nation" suggests, because while software and related high-tech services still accounted for approximately 69% of high-tech output, the principal source of incremental growth in 2025 was hardware manufacturing—including computers, electronic and optical equipment—which added approximately NIS 16 billion of output in a single year, compared with annual additions of no more than approximately NIS 1.5 billion during 2022–2024, a shift that matters for Europe because it positions Israel not only as a supplier of software, cybersecurity and enterprise applications but increasingly as a source of technologies located closer to physical infrastructure, advanced electronics, semiconductor systems, sensors, communications hardware and the industrial interface between artificial intelligence and machines.

This is precisely why technological disengagement would be strategically different from reducing ordinary imports from a politically controversial country: alternative commodity suppliers can frequently be found without materially changing an industry's technological frontier, whereas innovation networks are composed of difficult-to-replicate combinations of specialised researchers, entrepreneurs, venture capital, military and civilian engineering experience, university laboratories, multinational R&D centres, intellectual-property portfolios, early adopters and highly compressed feedback loops between prototypes and deployment, meaning that removing one of those networks from European corporate and academic access does not automatically cause another ecosystem with equivalent technological density to appear in its place.

Israel's technological relevance to Europe is already institutionalised through the European research architecture

The idea that Israel sits outside the European scientific system and merely sells technology into Europe is contradicted by the institutional record, because Israel has participated in European research framework programmes since 1996, signed its Horizon Europe association agreement in December 2021, and remains listed by the European Commission among the countries associated with Horizon Europe, a status that grants Israeli researchers and entities, subject to the programme's rules and current political decisions, rights and obligations broadly comparable to those of participants from EU Member States.
European Commission — International cooperation with Israel in research and innovation

The depth of this relationship is measurable rather than rhetorical: according to the European Commission's Directorate-General for Research and Innovation, Israel participated in 1,694 Horizon 2020 projects through 2,105 individual participations and secured approximately €1.3 billion, while by April 2025 Israeli entities had accumulated 909 participations in 747 Horizon Europe grants representing approximately €831 million, and the fourth EU–Israel Joint Committee on research and innovation was still discussing cooperation under Horizon Europe's collaborative Pillar II as well as participation in the European Innovation Council, European Research Council, Marie Skłodowska-Curie Actions and European Institute of Innovation and Technology.
European Commission — EU-Israel research and innovation cooperation, 2 April 2025

These figures change the strategic meaning of the current political debate, because measures affecting Israel's participation in European programmes do not concern an external ecosystem with which Europe maintains only occasional scientific contacts; they concern a partner that has accumulated three decades of integration into European research programmes, thousands of project-level connections and institutional familiarity across multiple scientific disciplines, which means that any broad interruption would affect networks already embedded in European laboratories and consortia rather than merely preventing future commercial transactions.

The relevant European question is therefore not simply whether the Union possesses the sovereign legal authority to alter association arrangements—which it does under the governing agreements and applicable procedures—but whether policy-makers accurately price the technological opportunity cost when access to research and innovation programmes becomes an instrument of geopolitical pressure, particularly when Europe's own strategic documents repeatedly identify artificial intelligence, quantum technologies, semiconductors, cyber resilience, biotechnology, clean technology and defence innovation as areas in which the continent needs greater rather than smaller access to advanced external knowledge.

Artificial intelligence — Israel is positioned across both applications and the enabling infrastructure beneath them

Israel's importance in artificial intelligence does not rest only on the number of startups using commercially available generative-AI models, because the Israel Innovation Authority's deep-tech mapping identifies more than 2,000 AI companies operating in Israel, of which 538 qualify as deep-tech companies, including 146 focused on AI infrastructure and 392 working on advanced applications in areas such as agriculture, pharmaceuticals and semiconductor technologies, while AI-focused Israeli deep-tech companies raised approximately US$3.4 billion between 2019 and 2025.
Israel Innovation Authority — Deep-Tech in Israel

The direction of investment is becoming even more concentrated around AI: the Innovation Authority reported in its 2026 strategic assessment that approximately 32.5% of all investment in Israeli high-tech in 2025 went to Core AI companies, while the Authority's national AI strategy defines Israel's competitive objective not as attempting to match the aggregate computing scale of the United States or China but as occupying high-value segments of the AI stack in which specialisation, engineering speed and domain expertise can compensate for smaller domestic scale, including vertical AI applications, semiconductor and communications infrastructure, cybersecurity, data-centre technologies and what the Authority describes as Physical AI, meaning systems in which AI interacts with robotics, sensors, autonomous platforms and real-world industrial processes.
Israel Innovation Authority — National AI Strategy for Israeli High-Tech 2026

For Italy, this matters because the Italian industrial problem in AI is not simply access to foundation models; it is the integration of AI into manufacturing, mobility, energy networks, medical equipment, aerospace, defence, robotics and other sectors in which Italy retains substantial industrial strengths but does not possess the same density of specialised venture-backed software and deep-tech development found in Israel, creating a potentially complementary relationship in which Israeli companies contribute algorithms, sensors, cybersecurity, embedded software and specialised components while Italian firms contribute production engineering, certification expertise, large-scale manufacturing, European distribution and access to industrial customers.

Political disengagement therefore risks damaging precisely the type of cross-border technological complementarity that European industrial policy should be trying to create, because technological sovereignty does not require every component of an advanced system to have been invented domestically; it requires European companies to understand, integrate, industrialise and where necessary control critical technologies well enough to avoid strategic dependence, and Israeli innovation networks can contribute to that objective rather than contradict it.

Semiconductors and advanced hardware — an increasingly important but frequently overlooked part of the Israeli ecosystem

The semiconductor dimension is strategically important because Europe's vulnerability in advanced chips is one of the clearest examples of why geographic diversification of technology partnerships matters, and the Israeli deep-tech ecosystem has developed capabilities that extend from chip design and AI accelerators to communications components, specialised processors, sensing technologies and semiconductor-related intellectual property, even though Israel does not possess the manufacturing scale of East Asian foundry leaders.

The Israel Innovation Authority's 2025 deep-tech assessment found that semiconductor companies accounted for approximately 9.8% of all capital raised by Israeli deep-tech firms between 2019 and 2025, while Israel had produced six semiconductor companies that had reached either unicorn valuation or the report's broader "centaur" threshold, and semiconductors were among the four categories—together with artificial intelligence, cybersecurity and medical devices—that had each generated approximately US$24 billion in value creation within the Israeli deep-tech ecosystem.
Israel Innovation Authority — Israeli Deep Tech Report 2025

The structural significance is reinforced by Israel's policy response: the Innovation Authority's 2025 deep-tech financing initiatives explicitly identified semiconductors, energy, climate, quantum computing and health as strategic fields in which long development periods and large capital requirements create financing gaps that conventional venture capital does not always fill, and a separate technological-incubator programme included semiconductors, bio-convergence, agri-food technology, robotics and defence technology among the high-risk sectors targeted for state-supported ecosystem development.

For the European Union, which has spent considerable political and financial capital attempting to strengthen domestic semiconductor capability through the European Chips Act and related industrial programmes, reducing access to Israeli semiconductor innovation would therefore be difficult to reconcile with the objective of expanding the range of non-Asian and non-Chinese technological inputs available to European firms, particularly because Israel's comparative advantage is often concentrated not in capital-intensive wafer fabrication but in chip architecture, communications, specialised processors, cyber-secure hardware and design-stage intellectual property, precisely the upstream knowledge layers that can complement European fabrication and industrial systems.

For Italy the strategic relevance is especially direct because STMicroelectronics, one of Europe's most important semiconductor companies and a major component of the Italian-French industrial technology base, has maintained R&D activity in Israel, and the Italian Embassy in Tel Aviv has explicitly identified STMicroelectronics among the Italian companies that established research and innovation laboratories there.
Italian Embassy in Tel Aviv — Italy-Israel technological innovation cooperation and Italian industrial presence

That single fact is strategically more revealing than dozens of political statements about bilateral friendship, because a European semiconductor champion does not place R&D capacity in a foreign ecosystem for diplomatic symbolism; it does so because access to specialised engineers, startups, intellectual property and nearby research networks is expected to create industrial value.

Cybersecurity — one of the clearest examples of technology density that Europe would struggle to replace quickly

Cybersecurity is perhaps the sector in which Israel's technological concentration is most difficult to dismiss, because the Israel Innovation Authority's deep-tech analysis calculates that Israeli deep-tech cybersecurity companies raised approximately US$2.4 billion between 2019 and 2025, representing more than 20% of total global deep-tech cybersecurity fundraising, an extraordinary share for a country of Israel's population and economic size, while the Authority separately noted that cyber represented approximately 28% of private early-stage investment in Israel in 2025, despite accounting for less than 1% of the Innovation Authority's own early-stage investment precisely because the private financing market for Israeli cyber companies is already unusually deep.

This concentration is reinforced by the country's operational cyber architecture, in which the Israel National Cyber Directorate acts as the national civilian cyber-defence authority responsible for policy, technological capacity, incident handling and resilience of critical infrastructure, while its 2025 annual report recorded approximately 2,480 cyber alerts, a roughly 2.5-fold increase over the previous year, including 2,304 proactive notifications delivered to organisations based on indicators of targeted attacks, demonstrating the continuous interaction between state cyber defence, threat intelligence and the private technology ecosystem.
Israel National Cyber Directorate — official portal and 2025 annual-report summary

For Europe, the relevance is not that Israeli cyber products are uniquely indispensable or that European alternatives do not exist, because Europe, the United States and other allied markets possess major cybersecurity providers; rather, the significance lies in the concentration of entrepreneurial experimentation and specialist engineering, particularly in network security, cloud security, identity, endpoint protection, data security, infrastructure protection and technologies emerging from the interaction between military cyber expertise and civilian entrepreneurship, which creates a persistent pipeline of companies that larger global firms acquire or integrate.

The economic importance of that pipeline became particularly visible in 2025, when the broader Israeli technology market recorded record-scale exit activity and acquisitions concentrated heavily in AI, cybersecurity and other deep-tech fields, confirming that foreign corporations continue to assign substantial value to Israeli intellectual property despite the country's political and security environment.

For Italy the strategic connection is no longer theoretical, because the Italian government itself identified ICT, artificial intelligence and cybersecurity as one of the five principal pillars of the planned Italy–Israel Business & Innovation Forum, alongside energy and water technology, aerospace and defence, infrastructure and sustainable mobility, and pharmaceuticals and biotechnology, indicating that Rome's economic diplomacy regarded cyber cooperation as part of a broader industrial strategy rather than as a narrow security relationship.
Italian Trade Agency — Italy-Israel Business & Innovation Forum sectoral architecture

Defence technology — European procurement already demonstrates that political criticism and strategic dependence coexist

The defence relationship exposes perhaps the clearest contradiction between the political movement toward isolation and the material behaviour of European governments, because while sections of European politics have intensified pressure for restrictions on Israeli military and dual-use cooperation, European ministries of defence continue purchasing Israeli systems in areas where they judge Israeli technology to meet urgent operational requirements.

Israel's Ministry of Defense reported that defence exports reached an unprecedented US$19.2 billion in 2025, an increase of almost 30% from 2024, more than double the level recorded five years earlier and approximately four times the value recorded a decade earlier, while government-to-government agreements alone approached US$10 billion, meaning that more than half of the year's defence export volume was conducted through strategic state-to-state arrangements rather than ordinary commercial sales.
Israel Ministry of Defense — All-Time Defense Export Record, 2 June 2026

The composition of those exports demonstrates the technological breadth of the sector: missile, rocket and air-defence systems accounted for 29% of 2025 agreements, observation and optronics 22%, radar and electronic warfare 11%, manned aircraft and avionics 11%, command-control-communications and related systems 7%, weapon stations and launchers 6%, drones and unmanned systems 4%, satellites and space systems 3%, vehicles and armoured personnel carriers 2%, intelligence-information-cyber systems 2%, maritime platforms 2%, and ammunition and armaments 1%.

Europe accounted for 36% of Israel's defence exports in 2025, after accounting for more than half of Israel's defence agreements in 2024, and the Ministry explicitly attributed part of the 2025 record to expansion of the Arrow 3 air-defence transaction with Germany, while its participation at ILA Berlin 2026 was presented as a vehicle for strengthening strategic partnerships with Germany and other European states.
Israel Ministry of Defense — Israeli defence delegation at ILA Berlin 2026

These figures make one point impossible to avoid: whatever political language European institutions employ toward Israel, European defence ministries continue to regard Israeli defence technology as strategically valuable, particularly in air defence, sensors, radar, electronic warfare, optronics, drones and command-and-control systems, and Europe is therefore simultaneously debating restrictions on technological relations while constituting one of the largest markets for technologies produced by the same national ecosystem.

That does not mean Europe should subordinate foreign policy to procurement needs, nor does it immunise Israeli defence companies from export-control, humanitarian-law, sanctions or procurement scrutiny; it means that a government-level assessment must acknowledge the real trade-off, because severing Israeli defence-technology relations would not simply impose costs on Israel but would require European armed forces to replace capabilities for which they are currently committing billions of dollars precisely because equivalent systems are not always available at the required combination of performance, maturity, delivery schedule and price.

Water technology — Israel's value lies in the integration of desalination, reuse, irrigation and management rather than in one invention

Water is another field in which Israeli technological significance is frequently reduced to slogans about desalination or drip irrigation when the more important achievement is systemic: Israel developed an integrated model combining large-scale desalination, wastewater reuse, demand management, aquifer management, precision irrigation and crop selection in response to chronic structural water scarcity, creating both technological products and accumulated operational knowledge relevant to Mediterranean countries facing climate-driven water stress.

An official Israeli government water-innovation publication states that more than 87% of wastewater is reused, with reclaimed water supplying more than 40% of agricultural irrigation demand, while large-scale desalination was developed specifically to make desalinated water a principal source of municipal supply, demonstrating a system in which wastewater reuse and desalination are not pilot technologies but infrastructure-scale components of national water management.
Government of Israel / MASHAV — Key Innovations in the Israeli Water Sector

The relevance to Italy is direct because Italy faces increasing drought risk, agricultural water stress, competing municipal and irrigation demands and substantial regional differences in water infrastructure performance, especially across the Mediterranean and southern regions; Israeli technology therefore offers value not because Italian engineers are incapable of developing water infrastructure, but because decades of continuous deployment under scarcity have generated operational data, design experience, companies and technologies that can be integrated into Italian and European systems without requiring Europe to rediscover every solution independently.

The Italian government recognised this complementarity explicitly when it included energy transition and water technology, including agricultural applications, among the central sectors of the Italy–Israel Business & Innovation Forum, alongside AI, cybersecurity, aerospace, defence, mobility, pharmaceuticals and biotechnology.

A blanket technological boycott would therefore create an especially irrational outcome in this sector: Mediterranean states facing worsening climate and water pressure would voluntarily restrict cooperation with an ecosystem that has spent decades solving exactly those operational problems, not because the technologies themselves were shown to create an unacceptable security or legal risk, but because they originated in a politically contested state.

Agriculture and food technology — Israeli innovation increasingly targets the productivity and resource constraints confronting Europe

Agricultural technology occupies a similar position because Israel's historical scarcity of arable land, freshwater and predictable rainfall encouraged investment in irrigation, crop optimisation, controlled-environment agriculture, sensing and resource-efficient agricultural systems, while the contemporary ecosystem has expanded into precision agriculture, alternative proteins, food technology, biological inputs, robotics, agricultural AI and climate adaptation.

The Israel Innovation Authority's deep-tech analysis found that Israeli companies captured approximately 9–10% of global deep-tech investment in AgriFood, a share dramatically disproportionate to Israel's size, while the Authority's funding structure shows that agri-tech, food-tech and water collectively accounted for approximately 11% of its investments in 2025 compared with only around 1% of private capital investment, indicating deliberate state intervention in technologies considered strategically important but difficult to finance because of long development timelines and physical deployment requirements.

The earlier 2025 Innovation Authority analysis similarly reported that food-tech, agri-tech, water and energy together represented approximately 23% of Authority investment, compared with only around 4% of private early-stage investment, which demonstrates that Israel's innovation strategy is consciously attempting to broaden beyond commercially mature software and cyber sectors into climate- and resource-related deep technology.

This is strategically relevant for Italy because agriculture remains simultaneously an economic sector, a food-security asset, a major water user and a core element of regional identity and export competitiveness, meaning that technologies capable of reducing water intensity, improving crop monitoring, managing heat stress, optimising fertiliser use or increasing productivity under climatic volatility have direct implications for Italian national resilience.

The relationship therefore has a logical industrial division of labour: Israeli startups can develop highly specialised technologies under conditions of resource scarcity and intensive venture experimentation, while Italian agricultural regions, machinery manufacturers, food companies and research institutions possess large-scale production environments in which those technologies can be tested, industrialised and integrated into established value chains.

Energy and climate technology — cooperation combines innovation scouting with Europe's much larger deployment market

In energy and climate technology, Israel's significance is again concentrated less in generation scale than in technological niches, because the country's relatively small electricity market means it cannot compete with Europe, China or the United States in aggregate deployment, but it can generate technologies in energy management, grid cybersecurity, storage, hydrogen-related systems, advanced materials, power electronics, optimisation software and climate-tech applications that are valuable to multinational utilities and infrastructure companies.

The Israel Innovation Authority specifically identifies energy and climate technologies among the deep-tech domains in which public intervention is required because technological risk, development time and capital requirements are too high for many private investors, and its 2025–2026 financing programmes therefore allocate targeted support to companies operating in these areas rather than concentrating exclusively on easier-to-finance software businesses.

Italian corporate behaviour provides more concrete evidence than policy rhetoric: the Italian Embassy in Tel Aviv has documented that Enel established a technology hub in Tel Aviv and an innovation laboratory in Haifa, later winning through Enel X a further innovation-lab initiative in Beersheba, while Snam entered agreements with the Israel Innovation Authority to identify startups and develop industrial partnerships, illustrating that major Italian energy groups were using Israel as a technology-scouting environment rather than treating it merely as a destination for Italian exports.
Italian Embassy in Tel Aviv — Italy-Israel scientific and industrial cooperation for technological innovation

This distinction is essential because a technology hub performs a different function from an ordinary subsidiary: the objective is to place a corporation physically inside an innovation ecosystem so that it encounters startups, researchers, investors and technologies earlier than competitors relying solely on mature commercial procurement, and the value therefore consists partly in information—knowing what is emerging, which teams are credible and which technologies are approaching industrial viability before they become widely available.

Political separation would weaken this informational advantage even if Italy could later buy similar technologies on the open market.

Health, medical devices and biotechnology — one of Israel's strongest deep-tech domains

Health technology is another area in which Israel's innovation position is quantitatively substantial, because according to the Innovation Authority's 2025 deep-tech assessment, medical devices and pharmaceuticals together absorbed approximately US$7.4 billion of Israeli deep-tech investment between 2019 and 2025, representing roughly one quarter of all capital raised by the country's deep-tech companies over that period, while Israeli medical-device firms accounted for approximately 9–10% of global deep-tech investment in the sector.

The importance of this sector derives from the interaction of several capabilities—clinical data, engineering, software, sensors, imaging, biomedical research and venture finance—rather than from a single national champion, which is precisely the ecosystem model that Italy has often struggled to reproduce at comparable density despite possessing strong universities, hospitals, pharmaceutical companies and biomedical manufacturing districts.

The Italian Trade Agency's own sectoral activity reflects this assessment, identifying Israel as an advanced health-tech environment and noting approximately 1,810 active health-tech companies in 2022, while describing the bilateral scientific and industrial agreement as one of the financing channels supporting cooperation among startups, SMEs and research organisations.
Italian Trade Agency — Israel health technology ecosystem and bilateral cooperation

For Europe, and particularly for ageing societies such as Italy and Germany, access to innovations in diagnostics, digital health, minimally invasive devices, medical imaging, clinical decision tools and biotechnology has direct fiscal as well as industrial relevance, because technologies that shorten hospital stays, improve early diagnosis, automate clinical workflows or reduce treatment cost affect the sustainability of healthcare systems in addition to creating commercial value.

The policy implication is therefore broader than the question of whether an individual Israeli medical startup can relocate to the United States if Europe closes its doors; Europe itself loses optionality, competition and access to technological diversity when it removes a highly innovative source ecosystem from its research and procurement networks.

Sustainable mobility — the Italy–Israel relationship already contains an explicit industrial model

The automotive and mobility relationship provides one of the clearest examples of how Israeli innovation can complement Italian manufacturing, because the partnership concluded between Stellantis and the Israel Innovation Authority was constructed specifically around this division of capabilities: the Authority would identify Israeli startup technologies responding to Stellantis's industrial needs and support their development, while FCA Italy, wholly owned by Stellantis, would help successful startups scale their technologies, connect them to R&D networks and gain access to the group's commercial and marketing infrastructure.
Italian Embassy in Tel Aviv — Stellantis and Israel Innovation Authority cooperation agreement

This architecture is worth examining closely because it demonstrates why the relationship cannot be captured by import-export statistics: the Israeli side contributes discovery and early-stage technological development, while the Italian-European side contributes industrial validation, scaling, manufacturing integration and international market access, creating a bidirectional innovation chain in which each ecosystem supplies capabilities the other lacks at comparable scale.

The same Embassy statement placed Stellantis within a wider pattern that included Enel and STMicroelectronics, which had established innovation or R&D presences in Israel, and Sparkle, Snam and Adler, which had concluded agreements with the Israel Innovation Authority intended to develop industrial partnerships with Israeli high-tech startups.

The Italian diplomatic assessment at the time was explicit: Israel provided a fertile environment in which major Italian companies could identify research and innovation projects, while the Italian manufacturing system could serve as a natural platform through which Israeli companies industrialised their technologies and entered global markets; stripped of diplomatic language, this describes a deliberate national strategy for connecting Italy's mature industrial base with Israel's stronger startup-generation mechanism.

The strategic question raised by contemporary anti-Israel disengagement campaigns is therefore whether Italy intends to dismantle a model that its own government spent years constructing precisely because Italian industry recognised deficiencies in domestic startup scaling, corporate innovation and access to rapidly developing technologies.

Italy's cooperation architecture is unusually broad because it was designed around complementary technological strengths

The bilateral relationship was institutionalised through the Agreement on Industrial, Scientific and Technological Cooperation between Italy and Israel, which created the governmental framework through which joint research projects, industrial R&D and later specialised laboratories could be supported, while the continuity of that framework is demonstrated by the Italian Ministry of Foreign Affairs' decision to maintain bilateral calls well after the Gaza war had transformed the European political environment.

The most relevant current evidence is the MAECI call for a joint Italian–Israeli laboratory, which remained open until 20 July 2026 and explicitly provided for Italian government financing of the selected project under the bilateral agreement and national legal framework.
Italian Ministry of Foreign Affairs — 2026 Italy-Israel joint laboratory call

This matters because the call was not merely the passive continuation of an old treaty; it required current administrative action, current funding and current willingness to select new collaborative activity, providing strong evidence that at the national-government level Italy continued to regard Israeli science and technology as worth integrating into the Italian innovation system even while sections of Italian academia were demanding suspension of the same bilateral framework.

The sectoral logic had already been made explicit by the Italian government and ICE Agency when preparing the Italy–Israel Business & Innovation Forum around energy transition and water technology, ICT/AI/cybersecurity, aerospace and defence, infrastructure and sustainable mobility, pharmaceuticals and biotechnology, a portfolio that closely overlaps with the sectors Italy and the European Union now classify as strategically important for technological sovereignty.

The institutional contradiction is therefore stark: the sectors most exposed to political pressure for disengagement are substantially the same sectors in which the Italian state previously invested diplomatic and commercial resources to obtain greater access to Israeli technology.

The deep-tech structure shows why replacing Israel is not equivalent to finding another trading partner

Israel's most important technological characteristic is not simply the number of startups but the unusually high density of companies attempting complex technologies with long development cycles and significant engineering risk, because according to the Innovation Authority and Dealroom's 2025 mapping approximately 1,500 Israeli deep-tech companies were operating across the ecosystem, more than US$28 billion had been raised by deep-tech firms between 2019 and 2025, and the cumulative valuation of private Israeli deep-tech companies had exceeded US$177 billion.

The report placed Israel among the Western world's strongest deep-tech ecosystems outside the United States, with particularly strong positions in AI, medical devices, semiconductors, cybersecurity and AgriFood, while approximately 1,000 companies remained at relatively early fundraising stages, indicating that the visible mature companies represent only part of the technological pipeline.

This distinction is crucial for European policy because a mature company can often be purchased from later, whereas a deep-tech ecosystem generates early knowledge about technologies that have not yet reached commodity status; corporate innovation offices, venture arms and research partnerships therefore seek access precisely before technologies are widely commercialised, allowing companies to influence product development, secure partnership rights, invest early or integrate capabilities ahead of competitors.

If Italian universities and corporations progressively withdraw from Israeli networks while American and Asian competitors continue participating, Israel does not disappear as a technology ecosystem; rather, the distribution of access shifts away from Europe, creating the possibility that technologies initially developed in Israel are commercialised, financed, acquired and scaled primarily through United States-based companies before European firms gain meaningful access.

The effect would therefore be less an Israeli technological loss than a European intermediation loss.

The relationship is reciprocal, which means Europe has leverage but also exposure

A serious government assessment must also avoid the opposite exaggeration—that Israel can operate independently of Europe and that European restrictions would therefore be self-defeating only for Europe—because the Innovation Authority's own data show that Israeli high-tech is extraordinarily dependent on international markets, with exports representing approximately 79% of sector output, while the 2026 report warns that Israeli technology companies are increasingly expanding employment, management and R&D activity abroad and that international connectivity remains a structural requirement for continued growth.

The Authority explicitly states that international alliances, semiconductor access, computing capacity and international research cooperation are prerequisites for maintaining Israeli leadership in AI and other emerging technologies, which means Europe possesses genuine leverage through market access, research programmes, capital, procurement and industrial partnerships.

That leverage, however, does not eliminate Europe's own exposure, because interdependence means precisely that both sides absorb costs when links are severed; the relevant policy problem is consequently not whether Brussels can hurt Israeli high-tech—it can—but whether the political objective being pursued justifies the corresponding reduction in European access to Israeli innovation, and whether targeted measures against demonstrably problematic entities can achieve the same policy objective at lower technological cost than nationality-wide restrictions.

This distinction should form the basis of any government response to boycott demands: where a specific company, laboratory or project presents a documented legal, export-control, security or human-rights concern, targeted exclusion is compatible with both accountability and technological rationality; where exclusion expands to Israeli entities generally, Europe begins paying an innovation cost that is no longer tied directly to the conduct supposedly being sanctioned.

Why Italy has more to lose than bilateral trade statistics suggest

Italy's exposure is structurally different from that of countries possessing stronger domestic venture ecosystems because Italy has exceptional strengths in manufacturing, machinery, automotive systems, aerospace, energy infrastructure, pharmaceuticals, food processing and industrial design but has historically faced weaker scaling conditions for high-growth technology startups, a smaller venture-capital market and more limited commercialisation of university research than the United States or Israel, which means that access to external startup ecosystems can compensate for domestic weaknesses without requiring Italy to recreate the entire innovation chain internally.

The Italy–Israel model developed over the previous decade reflected exactly this logic: Italian institutions supported startup acceleration in Israel, large Italian corporations established innovation presences or formal agreements with the Israel Innovation Authority, and economic diplomacy deliberately connected Israeli startups to Italian industrial groups capable of manufacturing and global distribution. The Italian Embassy's documentation of Enel, STMicroelectronics, Sparkle, Snam, Adler and Stellantis/FCA Italy demonstrates that this was not a niche programme for small technology firms but a network reaching into strategically important Italian industrial groups.

The consequence is that decoupling would not principally remove finished Israeli products from Italian shelves; it would reduce access to an upstream innovation pipeline that Italian companies deliberately entered because it provided capabilities difficult to source domestically at equivalent density.

That cost is harder to communicate politically because no single factory closes when a research relationship is abandoned and no immediate GDP collapse follows the cancellation of a university agreement, but the cumulative effect appears later through fewer startup partnerships, slower technology scouting, reduced co-development, fewer patents, diminished exposure to specialist engineering networks and greater dependence on technologies acquired after they have already been commercialised by competitors.

For a country seeking to close productivity and digitalisation gaps with the United States and leading Asian economies, that is not a marginal consideration.

European strategic autonomy does not logically imply isolation from Israeli technology

The argument that Europe should reduce technological dependence on external actors is legitimate, but it does not logically follow that Europe should minimise cooperation with every non-EU innovation ecosystem, because strategic autonomy is better understood as the capacity to preserve freedom of action through diversified supply, domestic competence, interoperable partnerships and control over critical dependencies rather than through technological self-sufficiency, which is neither economically realistic nor technologically efficient across the full spectrum of advanced sectors.

Israel can therefore strengthen European strategic autonomy in certain domains precisely because it offers an additional source of technology outside the dominant United States–China axis, particularly in cybersecurity, specialised semiconductor design, sensors, air defence, medical devices, water technologies and agricultural innovation, provided that Europe avoids replacing one dependency with another and subjects cooperation to appropriate security, ownership, export-control and supply-chain screening.

From this perspective, treating Israeli technology as intrinsically problematic because of the nationality of the supplier can produce the opposite of the intended result: fewer suppliers, greater concentration of technology acquisition in larger US corporations, reduced competitive tension and diminished European knowledge of emerging technologies.

The correct industrial-policy objective is therefore selective technological sovereignty, not indiscriminate technological separation.

Sectoral evidence of Israel's role as a European technology node

Technology domain	Verified Israeli capability indicator	European/Italian relevance	Principal official record
High-tech economy	NIS 352bn output; 18.3% of GDP; US$85bn exports; 58% of national exports in 2025	Demonstrates systemic rather than niche technological capacity	Israel Innovation Authority 2026
AI	32.5% of 2025 Israeli tech investment directed to Core AI; more than 2,000 AI companies mapped	Industrial AI, cybersecurity, chips, health, agriculture and autonomous systems	Israel Innovation Authority
Deep tech	Approximately 1,500 companies; >US$28bn raised since 2019	Access to early-stage technologies beyond software	Israel Innovation Authority / Dealroom
Semiconductors	9.8% of deep-tech capital; six major unicorn/centaur companies identified	Complements European chip-design and industrial-electronics objectives	Israel Innovation Authority
Cybersecurity	Israeli deep-tech firms captured >20% of global deep-tech cyber investment	Cyber resilience, cloud, critical infrastructure, defence	Israel Innovation Authority
Defence	US$19.2bn exports in 2025; Europe 36%	Air defence, radar, EW, optronics, C4I, drones, space	Israel Ministry of Defense
Medical devices	Approximately 9–10% global deep-tech investment share	Healthcare productivity, medtech, diagnostics	Israel Innovation Authority
AgriFood	Approximately 9–10% global deep-tech investment share	Climate resilience, water efficiency, precision agriculture	Israel Innovation Authority
Water	>87% wastewater reuse; >40% of irrigation needs supplied by reclaimed water	Mediterranean drought adaptation and irrigation	Government of Israel / MASHAV
Mobility	Stellantis/FCA Italy–Israel Innovation Authority partnership	Startup technology integrated into European automotive industrialisation	Italian Embassy Tel Aviv
Energy	Enel innovation presence; Snam partnership with Israeli innovation ecosystem	Grid, energy management, climate and infrastructure technology	Italian Embassy Tel Aviv
Semiconductors/ICT	STMicroelectronics R&D presence; Sparkle cooperation	European electronics and communications capability	Italian Embassy Tel Aviv

The evidence in this table does not establish that Israel is irreplaceable in any of these domains, because no technologically serious assessment should claim that one external country has a monopoly over innovation; what it establishes is that Israel represents an unusually dense additional source of capabilities across a combination of sectors that closely match Europe's own strategic technology priorities, meaning that the burden of proof should rest on those advocating broad technological exclusion to demonstrate that the foreign-policy benefit exceeds the resulting industrial and scientific cost.

The paradox of political disengagement becomes most visible when Europe continues buying the technology

Perhaps the most revealing indicator is the coexistence of boycott pressure in universities with record European purchases of Israeli defence technology and continued European research participation, because this demonstrates that the political system is not actually converging on a coherent conclusion that Israeli technology lacks value; rather, different institutions are applying different standards according to sector, political visibility and immediate operational need.

A university senate can suspend an Israeli academic agreement because the political cost of doing so is largely reputational and the technological loss is diffuse and delayed, whereas a defence ministry deciding whether to acquire an air-defence system must confront immediate performance requirements, delivery schedules and threat assessments, which creates a much more explicit opportunity cost; unsurprisingly, Europe still accounted for 36% of Israeli defence exports in 2025, and Germany's expanded Arrow 3 procurement contributed to Israel's record year even while European institutions debated measures restricting Israeli access to civilian research and innovation support.

This divergence suggests that institutional disengagement is currently strongest where the technological cost is least visible to the decision-maker, not necessarily where Israeli technological relevance is weakest.

That is precisely why government coordination is needed.

Strategic implications for Italy

For Italy, the correct policy question is not whether political criticism of Israel should cease, because foreign-policy judgments belong to the government and Parliament and can legitimately produce diplomatic or economic consequences; the strategic issue is whether those consequences should be translated indiscriminately into the scientific and industrial sphere, where broad exclusion may damage Italian capabilities without materially altering the conduct it seeks to influence.

The most defensible framework would preserve the bilateral scientific agreement, Horizon collaboration and industrial partnerships while subjecting specific high-risk projects to transparent controls covering dual-use technology, military end-use, sanctions exposure, export licensing, human-rights risk, ownership and critical-infrastructure security, because this allows Italy to exercise political and legal scrutiny without dismantling an innovation bridge whose usefulness has been demonstrated by its own corporations and ministries.

Italy should also distinguish between technology acquisition and technology absorption, because simply purchasing Israeli products does little for sovereignty if Italian industry does not acquire engineering knowledge, participate in co-development, build domestic production capacity or integrate intellectual property into European value chains; the strongest model is therefore not dependency on Israeli suppliers but structured technological reciprocity, in which Israeli innovation is combined with Italian manufacturing, laboratories, certification, infrastructure and market scale.

The Stellantis–Israel Innovation Authority arrangement already illustrates this principle: Israeli startups supplied innovation, but FCA Italy participated in scaling, R&D integration and global industrialisation, creating a relationship in which Italian industry was not a passive consumer.

The same logic can be applied to water technologies, agritech, cybersecurity, energy, AI, semiconductors and health.

The strategic cost of turning nationality into a technology-screening criterion

The most serious long-term risk created by the anti-Israel pressures examined in Pillar I is therefore not the cancellation of any single agreement but the normalisation of a principle under which the nationality of an innovation ecosystem becomes a proxy for technological risk, because once origin replaces project-specific assessment, governments and universities cease distinguishing between technologies that present genuine security or ethical concerns and technologies whose only connection to a contested government policy is the nationality of the researchers or shareholders that developed them.

Such a model is analytically weak because technology ecosystems are internally heterogeneous: a medical-device startup, a university AI laboratory, an irrigation company, an air-defence manufacturer, a settlement-linked construction business and a cybersecurity company do not generate the same legal, ethical or security questions merely because they are Israeli, just as European institutions do not normally treat every American, Chinese, Turkish, Saudi, Indian or Emirati technology company as interchangeable with the foreign-policy record of its government.

The proper state response is therefore not immunity for Israeli institutions but granularity.

Granularity means assessing the entity, the technology, the ownership structure, the intended end-use, the funding source, the legal exposure and the strategic dependency created by the transaction.

Once this principle is abandoned, political pressure ceases to function as governance and begins to function as collective economic attribution.

Key judgments

Israel's role in the European technology system is substantially larger than bilateral trade figures suggest because it operates through research programmes, multinational R&D centres, startup acquisition, corporate innovation partnerships, venture capital and specialised deep-tech networks, meaning that the loss from disengagement would appear primarily as diminished innovation access rather than as an immediate collapse in merchandise trade.

The scale of the ecosystem is objectively material: Israeli high-tech produced NIS 352 billion in output in 2025, represented 18.3% of GDP, generated US$85 billion of exports and accounted for 58% of national exports, while deep-tech activity spans approximately 1,500 companies and has attracted more than US$28 billion since 2019, with especially strong positions in cybersecurity, AI, semiconductors, medical devices and AgriFood.

Europe is already deeply integrated with this ecosystem through Horizon programmes, in which Israel accumulated 2,105 participations and €1.3 billion under Horizon 2020 and, by April 2025, 909 participations in 747 Horizon Europe grants worth approximately €831 million, demonstrating decades rather than months of institutional integration.

Italy has deliberately built its own connection through the bilateral scientific and technological agreement, MAECI funding, corporate R&D presences and agreements involving Stellantis/FCA Italy, Enel, STMicroelectronics, Sparkle, Snam and Adler, showing that Italian industrial policy historically regarded Israeli innovation as complementary to domestic manufacturing rather than as a competitor to it.

The defence market exposes the gap between political rhetoric and strategic behaviour most clearly, because European countries represented 36% of Israel's record US$19.2 billion defence exports in 2025, confirming that European governments continue acquiring Israeli capabilities even while parts of European politics and academia advocate broader technological isolation.

The defensible conclusion is consequently not that Italy or Europe would become technologically incapable without Israel, which the evidence does not support, but that deliberate broad-spectrum technological decoupling would remove one of the world's densest external innovation ecosystems from European access, reduce diversification, weaken certain industrial research channels and impose opportunity costs in sectors that Europe itself identifies as strategically critical.

What would change the assessment

The assessment would weaken if the Israeli technology ecosystem experienced a sustained multi-year collapse in venture investment, R&D employment, export competitiveness, multinational research presence and startup formation; if European firms demonstrated that Israeli technologies had been substituted at equivalent technological maturity, cost and performance without meaningful transition costs; or if Italy–Israel corporate and research partnerships declined naturally because their industrial value no longer justified continuation rather than because political institutions discouraged them.

The assessment would strengthen if Italian companies expanded innovation centres or co-development arrangements in Israel despite political pressure; if Horizon data showed continued high Israeli participation in strategically important EU technology programmes; if European defence procurement from Israel remained elevated or increased; if additional Italian corporations entered structured agreements with the Israel Innovation Authority; or if restrictions imposed by European academic institutions demonstrably reduced collaborative publications, patenting, consortium formation or startup partnerships without generating corresponding domestic technological replacement.

Open official record

A fully quantified assessment of Italy's technological exposure still requires several datasets that are not presently available in one harmonised official series, including the number and value of active Italian corporate R&D projects with Israeli startups, sector-level Italian investment in Israeli technology companies, the number of Italy–Israel co-patents and joint scientific publications over time, Horizon Europe consortium participation disaggregated specifically for Italian–Israeli pairings, the number of Israeli technologies incorporated into Italian critical infrastructure and industrial production, and a systematic measure of whether partnerships abandoned after 2024 were replaced by equivalent European or third-country technologies; until those records are assembled, the direction and strategic importance of the relationship are well supported, but the precise counterfactual cost of technological separation should be expressed as a material opportunity cost rather than converted into an unsupported numerical estimate.

Pillar III — Strategic Consequences for Italy and Europe

Principal judgment — The strategic risk is not the sudden disappearance of Israeli technology from Europe, but the progressive weakening of the research, industrial and human networks through which Europe acquires knowledge, diversifies technological risk and converts external innovation into domestic capability

The strategic consequence of the anti-Israel institutional pressures documented in the previous pillars is not best understood as an immediate binary choice between continued cooperation and total technological separation, because European innovation systems do not normally disintegrate through one political decision and multinational industrial relationships do not disappear merely because a university suspends an exchange agreement or a European institution proposes restrictions on one financing programme; the more realistic risk is cumulative fragmentation, in which researchers become less willing to build consortia with Israeli counterparts, universities add political and reputational tests to existing compliance procedures, companies become more cautious about partnerships that may trigger activist campaigns, public authorities narrow eligibility for programmes or procurement, venture networks redirect themselves toward jurisdictions perceived as politically safer, and Israeli scientists or technology companies gradually intensify relationships with the United States, India, Asia and other markets, leaving Europe not technologically isolated in any absolute sense but systematically less connected to one of the world's densest innovation ecosystems at precisely the moment when European institutions themselves acknowledge that insufficient connectivity, fragmented innovation markets and difficulties converting research into scalable commercial technologies constitute central weaknesses of the European economic model.

This strategic contradiction is already visible in the European Union's own competitiveness doctrine, because the Competitiveness Compass, presented by the European Commission in January 2025, places closing the innovation gap, strengthening decarbonisation and competitiveness, and reducing excessive dependencies while increasing security among the Union's principal transformational objectives, while a separate Commission research analysis published in June 2025, based on patent and scientific-publication data covering 2000–2023, concluded that European research and innovation hubs are significantly less interconnected than their American counterparts, particularly in complex technologies including artificial intelligence, biotechnology and quantum computing, and explicitly warned that fragmentation produces structural inefficiencies that damage European technological competitiveness.

That finding gives the Israel debate a strategic dimension extending far beyond the Middle East, because a Europe that simultaneously identifies inadequate connectivity as an innovation weakness and then allows political disputes to generate additional barriers between European researchers and a technologically dense external research system risks aggravating the problem it is spending substantial public resources to solve; the contradiction becomes even clearer when one recalls that Israel had accumulated 2,105 participations in 1,694 Horizon 2020 projects worth approximately €1.3 billion, and by April 2025 had already recorded 909 participations in 747 Horizon Europe grants securing approximately €831 million, meaning that cooperation with Israel is not an experimental diplomatic programme but a mature component of the European research architecture whose weakening would remove pre-existing connections rather than simply prevent hypothetical future ones.

The correct strategic assessment is therefore neither that Israel is indispensable to Europe nor that Europe can sever scientific and technological ties without meaningful opportunity costs, because neither proposition survives careful scrutiny; Europe possesses enormous domestic scientific capacity, world-leading universities, industrial champions and alternative partnerships with the United States, Japan, South Korea, Canada, Australia, India and other advanced economies, but Israel contributes a distinctive concentration of capabilities in cybersecurity, artificial intelligence, semiconductor design, defence technologies, advanced sensors, medical devices, water, agricultural technologies and startup commercialisation, and the relevant question for European policy-makers is consequently whether the political objective served by broad restrictions is sufficiently important to justify deliberately reducing the number, diversity and intensity of the external innovation networks available to European science and industry.

Innovation loss would emerge first as lost optionality rather than visible technological collapse

The economic cost of technological disengagement is particularly difficult to govern because innovation loss rarely appears as an immediately identifiable fiscal expenditure, closed factory or cancelled procurement contract, and instead emerges through opportunities that never materialise: a researcher who does not join a consortium, a corporate venture team that never encounters a startup, a patent that is licensed by an American rather than European company, a technology that reaches European markets only after a competitor has scaled it elsewhere, or a company that places its next research centre in Boston, Austin, Singapore or Bangalore rather than Milan, Munich, Paris or London.

This is why measuring only current bilateral trade would materially underestimate the exposure, because Israel's technological significance lies disproportionately upstream of mature product markets, where technologies remain embodied in startups, research laboratories, early patents, specialist engineering teams and venture-backed companies whose future commercial value is highly uncertain but whose potential upside can be very large, while the Israel Innovation Authority reported in May 2026 that the country's high-tech sector produced approximately US$85 billion in exports, almost US$15 billion in fundraising and roughly US$84 billion in exits during 2025, even as the same report warned of a decline in domestic R&D employment and continuing expansion of Israeli companies' management and research activity abroad.

The warning about R&D expansion outside Israel is particularly important for Europe because political isolation does not necessarily suppress the underlying technology; capital, founders and laboratories can relocate or deepen relationships with other innovation systems, which means that an indiscriminate European disengagement strategy can produce the paradoxical result that Israeli technologies continue to develop successfully while European companies become less involved in their financing, experimentation and industrialisation, thereby shifting future intellectual-property ownership, acquisition opportunities and technological influence toward non-European jurisdictions.

In strategic terms, the key variable is therefore optionality: the capacity of European universities, companies and governments to choose among a large set of technological partners rather than being confined to a smaller number of suppliers or innovation centres, because a diversified innovation architecture reduces exposure to any single foreign power while simultaneously improving the probability that European firms encounter emerging technologies early enough to shape their commercial development.

Removing Israeli technology networks from that portfolio does not automatically create European autonomy; unless the lost capability is replaced domestically or through equally productive alternative partnerships, it simply reduces European options.

Research fragmentation is especially dangerous because Europe already suffers from insufficient connectivity between its own innovation centres

The European Commission's June 2025 study “Divided we fall behind: Why a fragmented EU cannot compete in complex technologies” is unusually relevant to the consequences of politically driven research separation because, using extensive patent and publication data, it concluded that European innovation hubs are less interconnected than those of the United States and that this weakness is especially visible in complex technological fields such as AI, biotechnology and quantum computing, precisely the categories in which access to dense international networks of specialists can determine whether research remains academic or becomes commercially deployable technology.

Against that background, the progressive exclusion or discouragement of Israeli partners creates a second layer of fragmentation on top of Europe's existing internal problem, because Israeli institutions have been integrated into EU research programmes for decades and therefore form nodes within existing collaboration networks rather than standing outside them; dismantling such connections consequently has a higher cost than merely declining to add a new peripheral partner, since teams must replace expertise, reconfigure consortia, renegotiate intellectual-property structures, locate alternative laboratories and rebuild trust relationships that may have accumulated across multiple programme cycles.

The effect is potentially strongest in complex research where knowledge is tacit rather than fully codified, because an algorithm, patent or scientific paper reveals only part of the capability embodied in an expert team, while practical knowledge concerning experimental design, prototype failures, regulatory navigation, manufacturing constraints and market adoption often travels through personal relationships and repeated cooperation; once the network is weakened, the formal publication may remain accessible but the high-value tacit component becomes more difficult to reproduce.

This is why the impact of academic disengagement should not be measured solely by the number of cancelled bilateral agreements, because a university may preserve formal access to Horizon Europe while individual departments, principal investigators or consortium leaders quietly decide that Israeli participation creates excessive reputational or administrative complexity, producing a form of latent exclusion that is more difficult to document but potentially more damaging precisely because it changes behaviour before any formal prohibition is enacted.

Technology sovereignty requires more connections under stronger rules, not fewer connections under weaker analytical distinctions

The strategic-autonomy argument is frequently invoked on both sides of the Israel debate, yet technological sovereignty is often misunderstood as if sovereignty meant minimising reliance on external technology regardless of source, whereas the more defensible definition is the capacity to make autonomous policy and industrial choices because a state or economic bloc possesses sufficient domestic knowledge, diversified suppliers, secure infrastructure, intellectual-property access, skilled personnel and trusted partnerships to avoid coercive dependence on any single external actor.

Under that definition, reducing access to Israel can strengthen European sovereignty only when the relevant technology relationship creates an excessive or unacceptable dependency and Europe simultaneously possesses a credible replacement strategy; where cooperation instead adds a supplier, research partner or source of specialist knowledge to an already diversified portfolio, elimination of that relationship can actually decrease resilience by concentrating remaining dependence elsewhere.

The European Commission itself connects competitiveness with both innovation and dependency reduction rather than presenting them as alternatives, because the Competitiveness Compass identifies closing the innovation gap and reducing excessive dependencies as parallel imperatives, which implies that diversification, domestic capability-building and external cooperation must be balanced rather than treated as mutually exclusive.

Italy's own 2026 research policy follows the same logic: the Italian Ministry of Universities and Research announced more than €381 million for research infrastructure, innovation and technology transfer, including €50 million for highly specialised scientific and technical human capital as well as programmes involving quantum technologies, high-performance computing, artificial intelligence and advanced materials, and explicitly linked these investments to the technological autonomy and competitiveness of both Italy and Europe.

That policy objective would be difficult to reconcile with an indiscriminate shrinking of the country's international research network, because public investment in domestic laboratories yields greater strategic returns when those laboratories are integrated into multiple high-capability foreign ecosystems from which they can absorb methods, attract talent, co-develop intellectual property and benchmark themselves against global technological leaders.

The rational sovereignty model is therefore domestic reinforcement plus diversified external access, not domestic investment plus politically motivated contraction of international connectivity.

Italy faces a particularly important strategic trade-off because its industrial strength is greater than its startup-scaling strength

Italy's exposure deserves separate treatment because the Italian technological system differs structurally from Israel's: Italy possesses a very large industrial base, internationally competitive machinery, automotive, aerospace, pharmaceutical, energy, food, luxury, design and manufacturing capabilities, while Israel's comparative advantage is disproportionately concentrated in R&D-intensive startups, software, cybersecurity, advanced electronics, defence systems, life-science innovation and rapid commercialisation of research; these structures are not substitutes but complements, which is precisely why Italian corporations and government agencies spent years constructing mechanisms that connected Israeli startup generation with Italian industrial scale.

This complementary structure means that broad disengagement would impose a greater cost than simple trade substitution might suggest, because Italy does not need Israel primarily for commodity supply but for access to a technological discovery environment that can supplement weaknesses in domestic venture scaling and university-to-industry commercialisation, while Italian manufacturing provides exactly the industrialisation capacity, European market access and supply-chain depth that many Israeli technology firms lack.

The continuation of the bilateral scientific framework through 2026 confirms that the Italian state still recognised this value even after the political environment deteriorated sharply, because MAECI maintained a call for two joint laboratories under the Italy–Israel Industrial, Scientific and Technological Cooperation Agreement, with the call closing on 20 July 2026, demonstrating that national policy had not converged on the university-level boycott logic described in Pillar I.

This divergence creates a governance problem rather than merely a political disagreement: if the Foreign Ministry finances bilateral cooperation while universities independently discourage participation, the state may preserve the formal treaty architecture while losing its effective implementation capacity, and if corporations continue partnering with Israeli technology companies while academic institutions reduce collaboration, Italy can also generate a division between industrial pragmatism and university politics that weakens the research-to-commercialisation chain linking basic science, applied research, startups and industrial production.

Over the next five years, therefore, the most important Italian indicator will not be whether the bilateral agreement survives on paper, but whether Italian universities, laboratories and firms continue to generate new collaborative projects with Israeli partners rather than merely completing relationships that pre-date the current political cycle.

Industrial competitiveness will be affected asymmetrically across sectors, with the greatest exposure concentrated where Israel possesses unusually dense specialist ecosystems

The strategic cost of disengagement will not be uniform across the economy, because replacing an Israeli supplier of ordinary manufactured goods is fundamentally different from replacing access to specialist cybersecurity teams, semiconductor-design expertise, advanced sensors, deep-tech medical devices or early-stage AI companies, and the industrial consequence therefore depends on the technological specificity, maturity and substitutability of each relationship.

In cybersecurity, Europe has major domestic and American alternatives, but Israel's unusually concentrated cyber ecosystem increases competition and technological diversity, meaning that exclusion would narrow rather than eliminate available capability; in semiconductors, Israeli strength is concentrated more heavily in design, specialised processors, communications and intellectual property than in leading-edge foundry capacity, making cooperation potentially complementary to Europe's manufacturing ambitions; in defence, European governments have already demonstrated through procurement decisions that Israeli systems can satisfy urgent air-defence, radar, electronic-warfare and sensor requirements; in water and agriculture, Israeli operational experience under structural scarcity creates knowledge directly relevant to Mediterranean climate adaptation; and in medical devices and digital health, the value derives from rapid integration of software, engineering, data and clinical research.

The cumulative effect therefore resembles a portfolio problem: Europe can replace many individual Israeli technologies, but replacing the portfolio of innovation sources is more difficult because substitutes come from different jurisdictions, under different ownership structures, often at different levels of technological maturity, which increases transaction costs and can push Europe toward greater dependence on American technology conglomerates rather than greater autonomy.

That distinction is particularly important for Italy because Italian industry already imports considerable digital and software capability from larger non-European corporations; reducing access to Israeli startups may therefore not result in more Italian technology being used, but instead in greater reliance on US-based companies that acquire Israeli startups and then sell the resulting technology back into Europe at a later commercial stage.

In that scenario, anti-Israel disengagement would not create technological sovereignty; it would merely insert another foreign intermediary between European industry and Israeli-origin innovation.

The four-country European lens reveals fundamentally different strategic instincts

Italy — a fragmented system in which state-level cooperation and university-level disengagement coexist

Italy currently presents the most institutionally fragmented model among the major European states examined in this report, because the central government has maintained bilateral scientific cooperation and continued funding mechanisms into 2026, while important universities have adopted policies ranging from targeted ethical screening to broad suspension of Israeli institutional relations; the result is not a coherent national boycott but a decentralised environment in which research access can increasingly depend on the governance philosophy of an individual university, faculty or department, thereby raising transaction costs for companies and researchers attempting to build predictable multi-year partnerships.

The principal Italian strategic risk is consequently erosion through decentralisation rather than a single government prohibition, because autonomy allows numerous institutions to create separate eligibility tests that collectively weaken cooperation even if the bilateral treaty remains untouched.

Italy also has a large opportunity cost because its government is simultaneously investing hundreds of millions of euros in advanced research infrastructure, AI, HPC, quantum technology and technology transfer, meaning that excluding external high-capability partners without creating domestic replacements would undermine rather than reinforce the country's stated innovation objective.

Germany — preservation of scientific cooperation has been treated explicitly as a strategic distinction from political disagreement

Germany provides the clearest counter-model because the Federal Government explicitly rejected using Horizon Europe scientific cooperation as the appropriate vehicle for sanctioning Israel: during the federal government press conference of 1 September 2025, the Foreign Office stated that Berlin did not consider ending or sanctioning Horizon cooperation sensible because such a measure would hit scientific collaboration between German and Israeli researchers rather than constitute an appropriate instrument of pressure.

That position subsequently became even more explicit, with Chancellor Friedrich Merz stating during his inaugural visit to Israel that Germany had no interest in damaging economic or scientific cooperation with Israel and instead wanted to deepen and intensify it, a position that establishes a clear conceptual separation between criticism of Israeli government conduct and the strategic treatment of the Israeli research and industrial ecosystem.

Germany's position is particularly significant because Berlin is simultaneously pursuing renewed technological leadership, with Merz stating in February 2026 that Germany aimed to reach 3.5% of GDP in R&D expenditure and placed the Hightech Agenda Deutschland at the centre of efforts to convert research into economic value, including a strong emphasis on AI, making the preservation of Israeli scientific cooperation consistent with a broader strategy of maintaining access to advanced external technological networks rather than an isolated diplomatic gesture.

Germany therefore demonstrates that political criticism and technological engagement are not mutually exclusive: a government can oppose elements of Israeli policy while still concluding that breaking researcher-to-researcher relationships is strategically counterproductive.

France — a longstanding cooperation architecture has survived the political deterioration

France occupies an intermediate but institutionally significant position, because the French Ministry for Europe and Foreign Affairs describes scientific and technical cooperation with Israel as resting on a bilateral agreement dating to 1959, identifies France as Israel's fifth scientific and technological partner, and records an institutional architecture coordinated since 2004 through the French-Israeli High Council for Scientific and Technological Research and Cooperation.

More importantly, this architecture was not simply left dormant during the current political crisis: on 24 February 2026, France's Ministry of Higher Education and Research jointly with the Foreign Ministry launched a call for a new French co-chair of the Haut Conseil franco-israélien pour la Science et la Technologie, explicitly describing the body as responsible for orienting, steering and coordinating scientific and technological cooperation between France and Israel and noting that annual meetings alternate between the two countries.

A French government research profile updated in October 2025 further described Franco-Israeli scientific cooperation as being of a very high level and placed France fifth among Israel's scientific partners, behind the United States, Germany, the United Kingdom and Italy, which is strategically notable because it situates Italy itself among Israel's most important scientific partners and confirms that the European research relationship extends across multiple major states rather than through one bilateral channel.

France's strategic challenge is therefore less the existence of the relationship than managing the tension between strong political criticism of Israeli policy and a state scientific architecture that France continues to maintain because its research system derives measurable benefit from cooperation.

United Kingdom — science and technology cooperation has been framed explicitly as an instrument of growth and strategic advantage

The United Kingdom, although outside the European Union, remains indispensable to the European technology landscape because of its universities, venture-capital ecosystem, life sciences, AI sector and association with Horizon Europe, and its bilateral relationship with Israel provides perhaps the most explicit official articulation of the economic rationale for technological cooperation: the 2030 UK–Israel Bilateral Roadmap established approximately £20 million of commitments around science and technology, while the government states that the UK–Israel Tech Hub, created in 2011, had facilitated more than 250 partnerships with an estimated £1.2 billion economic impact to the United Kingdom.

The bilateral science memorandum signed in September 2023 covers sustainability, environmental protection, climate, clean energy, water, health, medicine, AI and space, provides for jointly funded projects, multi-site technology testbeds, scientist mobility and direct links between government, research organisations and higher-education institutions, and is intended to operate within a five-year framework with subsequent annual extension.

The UK government's own Science and Innovation Network still describes Israel as a priority partner and identifies health, clean growth and emerging technologies including AI, engineering biology and quantum as principal areas of cooperation, illustrating that London's technology strategy treats international collaboration with Israel as one component of a wider global science network rather than as a diplomatic concession.

The British case consequently demonstrates the scale of potential opportunity cost most clearly: the government has attached a quantified economic value to technology partnerships generated by the bilateral ecosystem, meaning that broad disengagement would require policy-makers to acknowledge not only an ethical or diplomatic rationale but also the commercial value being deliberately abandoned.

European coordination would become substantially more difficult if national approaches continue diverging

The divergence between Italy's decentralised restrictions, Germany's explicit defence of scientific cooperation, France's continuing bilateral science architecture and the United Kingdom's technology-partnership model creates a wider European coordination problem, because research and innovation ecosystems operate across borders and a consortium that is politically acceptable to one member state can become controversial in another, while private companies must manage different reputational, institutional and compliance environments across the same European market.

Such fragmentation is especially damaging in strategic technologies because scale matters: Europe competes with the United States and China not as a collection of twenty-seven isolated national innovation systems but through cross-border research infrastructures, multinational corporations, shared funding programmes and a single market, meaning that political fragmentation around Israel can create exactly the kind of internal friction the Commission's competitiveness strategy seeks to eliminate.

If Germany continues promoting German–Israeli science while an Italian university refuses Israeli institutional partnerships, a multinational research project does not simply resolve itself through national sovereignty; coordinators must redesign governance, allocate work packages differently and assess whether the Israeli participant can remain connected through German rather than Italian institutions, creating additional transaction costs even before any EU-level sanction is imposed.

The wider strategic risk is therefore a Europe in which political disagreement over Israel becomes another source of internal research fragmentation, layered on top of existing national differences in funding, regulation, procurement, taxation and capital markets.

Discriminatory-risk thresholds must distinguish legitimate legal screening from collective attribution

The hardest governance problem concerns the point at which legitimate scrutiny of Israeli government policy or specific Israeli institutions becomes discriminatory treatment of Israeli entities collectively, because neither extreme position is analytically sufficient: the fact that discrimination is a risk does not mean every restriction is discriminatory, while the fact that legitimate human-rights due diligence exists does not mean every nationality-wide restriction can be justified simply by describing it as ethical policy.

A government-grade framework should therefore use a graduated threshold based on the object of the restriction, the evidentiary connection between the entity and the alleged conduct, the comparability of treatment across jurisdictions, the existence of an appeal or review mechanism, and the proportionality of the remedy.

A restriction is at its strongest legal and governance footing when it concerns a named entity whose relevant conduct is documented through sanctions, court decisions, export-control restrictions, procurement exclusions, direct ownership relationships or demonstrable participation in prohibited activity, because the measure then addresses conduct rather than identity.

The evidentiary basis becomes progressively weaker when exclusion is extended from the responsible entity to affiliated entities without a demonstrated operational connection, then from affiliated entities to an entire institutional sector, and finally from a sector to Israeli institutions generally.

The highest discriminatory-risk zone is reached when an institution is required to condemn its own government, adopt a prescribed political position or demonstrate ideological distance as a condition of ordinary scientific cooperation, because such a test moves away from conduct and toward political certification.

The policy safeguard should consequently be simple in principle even if demanding in implementation: no institution should be excluded solely because it is Israeli where the same conduct would not trigger equivalent treatment if performed by an institution from another jurisdiction.

That standard does not immunise Israel.

It requires equality of scrutiny.

Antisemitism must be treated as a separate but intersecting security and governance risk

The relationship between anti-Israel activism and antisemitism requires exceptional precision because conflating the two would discredit genuine efforts to combat antisemitism, while pretending that no interaction exists would ignore the documented deterioration in Jewish security across Europe since October 2023.

The European Commission states that the period following the Hamas attacks of 7 October 2023 and the subsequent Middle East conflict produced levels of antisemitism unprecedented since the founding of the European Union, while the EU Agency for Fundamental Rights survey cited by the Commission found that 96% of Jewish respondents had encountered antisemitism online or offline, eight in ten believed antisemitism had increased, and 76% avoided displaying items in public that would identify them as Jewish.

More recent 2026 Commission monitoring adds another politically important dimension: a new Eurobarometer found that 55% of EU respondents considered antisemitism a problem in their country, but the figure rose to 73% in Italy and 74% in France, placing the two countries among those where public recognition of the problem was highest; the Commission simultaneously warns that country incident data cannot be directly compared because national authorities record different categories and use different reporting systems, an evidentiary limitation that should be preserved rather than converted into simplistic national rankings.

This environment matters to the technological and academic debate because the boundaries between state criticism, anti-Zionism, hostility toward Israelis and hostility toward Jews can become blurred in institutional practice even when they remain conceptually distinct, particularly where Israeli researchers are treated as political representatives of their state, Jewish students are expected to answer for military policy, academic partnerships become conditional on political declarations, or classical antisemitic imagery and conspiracy narratives are imported into campaigns ostensibly directed at Israeli institutions.

The European Commission uses the non-legally binding IHRA working definition as an important instrument in its anti-antisemitism policy and identifies, among other examples, holding Jews collectively responsible for actions of the State of Israel and applying double standards to Israel, while also preserving the principle that criticism of Israel similar to criticism directed at any other country cannot automatically be regarded as antisemitic.

That distinction provides a useful institutional safeguard: criticism of a government remains protected political discourse; evidence-based restrictions on particular entities remain legitimate governance; but transferring state responsibility to individuals or requiring Jewish or Israeli academics to demonstrate political innocence before ordinary participation crosses a substantially different threshold.

The antisemitism problem creates a second-order strategic cost for European research itself

Antisemitism is not only a civil-rights or security issue; in a knowledge economy it also has consequences for talent attraction, researcher mobility and institutional reputation, because scientists and entrepreneurs decide where to study, establish companies, raise families and conduct research partly according to whether they believe their identity will expose them to hostility or professional disadvantage.

If Israeli or Jewish researchers perceive European universities as environments in which they are increasingly expected to account for Israeli government policy, Europe risks losing exactly the type of highly skilled human capital it is simultaneously attempting to attract through research and innovation programmes.

The cost would be difficult to separate statistically from broader migration and employment trends, but the mechanism is straightforward: global scientific talent possesses considerable mobility, the United States and other advanced economies actively recruit researchers and founders, and a political environment perceived as hostile creates an additional push factor away from European laboratories.

For Italy this matters especially because the government's 2026 research-investment programme allocates substantial resources specifically to highly specialised scientific personnel and technology transfer, meaning that an institutional climate that discourages internationally mobile scientists would directly undermine the return on those investments.

Policy safeguards should preserve accountability without converting foreign-policy disputes into nationality-based technological exclusion

The most defensible European framework is neither unrestricted cooperation nor comprehensive boycott, but a layered risk architecture that preserves scientific access while allowing governments and institutions to intervene where identifiable legal, security or ethical risks exist.

The first safeguard should be entity-specific due diligence, under which restrictions require a documented connection between the relevant institution and the conduct at issue rather than mere incorporation or nationality.

The second should be technology-specific screening, especially for dual-use research, defence applications, critical infrastructure, cyber capabilities, advanced semiconductors, surveillance technologies and sensitive AI, where end-use, ownership and export-control risks justify enhanced scrutiny irrespective of nationality.

The third should be country-neutral comparability, requiring universities and public bodies to demonstrate that equivalent conduct by entities in other jurisdictions would trigger comparable review, because ethical governance loses legitimacy when the threshold changes according to political salience.

The fourth should be procedural review, ensuring that an affected university, researcher or company can understand the reasons for exclusion, submit evidence and obtain reconsideration rather than being subject to indeterminate reputational judgments.

The fifth should be separation of institutional responsibility from compelled political speech, meaning that cooperation should not depend on an institution issuing a prescribed declaration unless the content of that declaration has a direct legal relevance to the activity being funded.

The sixth should be continued protection of individual researchers and students, so that even where an institutional agreement is suspended, nationality alone does not prevent academic participation unless legally required.

The seventh should be strategic-impact assessment before major restrictions, requiring governments to identify which capabilities would be lost, whether substitutes exist, what transition time is required and whether the measure would increase dependence on another foreign supplier.

Applied together, these safeguards would allow Europe to pursue human-rights, foreign-policy and security objectives without collapsing all Israeli technological activity into a single political category.

Technology cooperation should be separated from dependency through co-development and localisation

Where Italy or Europe judges Israeli technology strategically valuable, the appropriate response should not be passive dependence but negotiated reciprocity, because technological relationships are most beneficial when they leave capability inside Europe rather than merely transferring money abroad.

In cybersecurity, this can mean joint development centres, Italian engineering teams and shared intellectual property; in semiconductors, joint design programmes linked to European fabrication; in defence, licensed production, maintenance capability and integration with European platforms; in water and agriculture, local deployment partnerships that transfer operational knowledge to Italian utilities and agricultural organisations; in healthcare, clinical validation and manufacturing inside Europe; and in AI, collaborative research combined with European data governance and computing infrastructure.

This model transforms cooperation from import dependence into capability accumulation.

It also provides the strongest answer to those who argue that technological relations with Israel inherently weaken European strategic autonomy, because autonomy is enhanced when cooperation is structured to increase European know-how, manufacturing capability and intellectual-property participation rather than simply purchasing completed systems.

The five-year outlook — the most probable trajectory is selective fragmentation rather than complete European decoupling

A defensible five-year forecast should avoid fabricated numerical probabilities because no reproducible base rate exists for the political trajectory of EU–Israel scientific relations, but current institutional behaviour supports three broad pathways whose indicators are observable.

Managed strategic separation of politics from science

Under the most favourable pathway for continued cooperation, European governments would maintain political and legal pressure on Israel where they judge it warranted while preserving a conduct-based distinction between the Israeli state and individual universities, researchers and companies; Bologna-type categorical measures would remain relatively exceptional, Italy's bilateral scientific programme would continue operating, Germany and France would maintain their research architectures, the United Kingdom would continue bilateral technology cooperation, Horizon Europe would remain accessible except where specifically restricted, and universities would increasingly use dual-use and human-rights screening rather than nationality-based prohibitions.

This pathway would preserve Europe's technological optionality while still allowing targeted exclusions, and it would be confirmed by new Italy–Israel laboratories, renewed Horizon consortia, stable co-publication levels, additional bilateral industrial R&D calls and a decline in university policies requiring broad institutional disengagement.

Progressive selective fragmentation

The balance of present evidence supports this as the central five-year pathway, because it is already visible: formal state cooperation survives, major European governments disagree over the appropriateness of research restrictions, universities adopt divergent policies, and EU-level proposals target particular financing or association benefits without creating a complete embargo.

Under this pathway, Europe would not sever Israeli technology relations, but cooperation would become increasingly sector-, institution- and country-dependent; defence ministries would continue purchasing selected Israeli systems, private companies would maintain high-value technology relationships, Germany and possibly the United Kingdom would remain relatively open, while some universities and public institutions elsewhere would adopt more restrictive criteria, making collaboration administratively complex and politically uneven.

The result would be neither strategic autonomy nor complete decoupling, but higher transaction costs, reduced network density and uneven access.

This is the most dangerous pathway precisely because its costs are incremental and therefore politically easy to ignore.

Broad institutional decoupling

A more severe pathway would emerge if EU-level restrictions expanded from the EIC Accelerator into broader Horizon participation, trade preferences and public procurement while major member states simultaneously suspended bilateral scientific frameworks and universities normalised categorical exclusions of Israeli institutions.

The observable indicators would include formal suspension of the Italy–Israel scientific agreement, major contractions in Horizon participation, CRUI-level coordination around Israeli exclusions, national procurement restrictions extending beyond legally sanctioned entities, substantial reductions in Italian–Israeli joint projects and visible relocation of Israeli corporate R&D and capital relationships away from Europe.

This pathway would impose significant costs on Israel because Europe remains an important market, research partner and source of capital, but it would also impose a non-trivial European opportunity cost by reducing access to Israeli technology and redirecting part of the ecosystem toward alternative global partners.

The public record does not currently establish that this pathway is inevitable.

The five-year consequences for Italy under the central pathway

If the present fragmented trajectory continues through approximately 2031, Italy is unlikely to lose access to Israeli technology completely, but the relationship will become substantially more selective and politically mediated, with industrial groups continuing cooperation where technology is difficult to replace while universities and public-sector organisations apply increasingly elaborate ethical, dual-use and reputational screening.

The most important economic consequence will probably not appear in bilateral trade statistics, because Italian corporations can continue buying mature Israeli technologies even while early-stage academic and research ties weaken; the deeper risk will instead be a gradual separation between upstream knowledge generation and downstream procurement, leaving Italy able to purchase technology after commercialisation but less involved in its earlier development.

That distinction matters enormously for technological sovereignty.

A country that buys mature technology controls less intellectual property and captures less learning than one whose universities and companies participate in the technology's development.

If Italian academic disengagement becomes structurally more extensive while corporate procurement continues, Italy could therefore become more dependent on Israeli technology in commercial form while becoming less connected to Israeli innovation in research form, an outcome that would satisfy neither the objectives of political disengagement nor those of strategic autonomy.

The consequences for Europe under the central pathway

Europe's aggregate scale means it can absorb the loss of any single external technology partner, but the strategic issue is cumulative: if geopolitical tensions encourage Europe to narrow cooperation simultaneously with China, Russia, Israel and other politically difficult partners while the United States remains the dominant source of digital platforms, advanced AI infrastructure, venture capital and many software technologies, Europe can unintentionally reduce diversification and become more dependent on the United States even while publicly pursuing strategic autonomy.

Israel matters in this equation because it functions as one of relatively few advanced innovation ecosystems outside the US, EU and East Asia that consistently generates globally competitive technology companies across several strategically important sectors.

Maintaining Israeli access therefore does not imply accepting political dependence on Israel.

It can provide Europe with another technological axis.

The optimal European strategy is consequently to deepen domestic capability while preserving the broadest possible portfolio of legally permissible external partnerships, intervening aggressively where genuine strategic dependency, security risk or documented misconduct exists, but refusing to convert political hostility toward a government into a general presumption against the people, universities and companies operating under its jurisdiction.

Strategic decision matrix

Policy approach	Immediate political effect	Innovation consequence	Sovereignty consequence	Legal/discriminatory risk	Five-year strategic result
Comprehensive nationality-based disengagement	High symbolic pressure	High loss of network optionality	Can increase dependency on substitute foreign ecosystems	High	More fragmented European research system
Broad institutional boycott with exemptions	Strong political signal	Significant uncertainty and chilling effect	Mixed; some dependency reduction but fewer suppliers	Medium-high	Declining academic links, continued selective industrial procurement
Conduct-based targeted restrictions	Focused political/accountability effect	Limited collateral innovation loss	Generally strengthens resilience when tied to genuine risks	Low-medium	Cooperation preserved with problematic activities removed
Enhanced dual-use and security screening	Limited symbolic effect	Preserves most civilian R&D	Strengthens technology-security governance	Low when applied consistently	Sustainable cooperation with safeguards
Unrestricted cooperation	Minimal political leverage	Maximum access	Risks uncontrolled strategic dependencies	Variable	High innovation access but inadequate risk mitigation
Co-development, localisation and targeted screening	Moderate political flexibility	High innovation retention	Strongest technology-sovereignty outcome	Low when rules are country-neutral	European capability accumulation rather than passive dependency

The table illustrates why the most forceful political response is not automatically the most strategically advantageous one: comprehensive disengagement maximises symbolic pressure but also maximises collateral technological cost, while a conduct-based and technology-specific model preserves most innovation benefits while allowing Europe to intervene against genuinely problematic activities.

Decision thresholds for Italy

Italy should regard the relationship as entering a materially higher strategic-risk category if university restrictions begin spreading from individual institutions into coordinated national policy, because a CRUI-wide presumption against Israeli agreements would transform decentralised activism into system-level disengagement.

A second threshold would be formal suspension of the bilateral scientific and technological agreement, because this would remove the national institutional counterweight that currently distinguishes the Italian state's position from the most restrictive university approaches.

A third threshold would be measurable deterioration in industrial participation, particularly if Italian companies begin closing Israeli innovation offices, cancelling technology-scouting programmes or withdrawing from joint R&D arrangements for primarily political rather than commercial reasons.

A fourth would be migration of Israel-specific political tests into ordinary public procurement and research funding without equivalent conduct-based criteria for other jurisdictions.

A fifth would be documented treatment of individual Israeli or Jewish researchers as representatives of Israeli state policy, because that would signal movement from institutional foreign-policy pressure into discrimination against individuals.

Decision thresholds for the European Union

At EU level, the decisive threshold would be movement from partial, instrument-specific restrictions toward a presumption against Israeli participation in Horizon Europe generally, because that would transform a targeted political countermeasure into systemic research disengagement.

A second threshold would be adoption of trade and procurement restrictions that affect broad classes of Israeli economic operators without entity-specific evidence.

A third would be convergence among major member states, particularly Germany, France and Italy, because present divergence remains an important brake on comprehensive EU technological separation.

A fourth would be measurable redirection of Israeli research participation away from Europe and toward the United States or Asia, because this would indicate that political uncertainty was changing the geographical architecture of innovation rather than merely creating temporary diplomatic friction.

What Europe should protect even during severe political disagreement

The most important strategic asset to preserve is the distinction between government, institution and individual, because abandoning that distinction produces both governance failure and discriminatory risk.

Governments are responsible for state policy.

Companies are responsible for their own conduct and the conduct legally attributable to them.

Universities are responsible for institutional decisions and programmes.

Researchers and students are responsible for their own actions.

Foreign-policy pressure becomes analytically unsound when responsibility moves automatically across those categories.

The second asset to preserve is scientific reciprocity, because cooperation should remain open where it produces mutual benefit and does not create unacceptable legal or security exposure.

The third is technological diversification, because reducing dependence on one external actor should not increase dependence on another.

The fourth is academic freedom, which includes the freedom to criticise Israel forcefully but also the freedom of researchers to collaborate with Israeli colleagues without being required to adopt a prescribed political view.

The fifth is the security and equal treatment of Jewish and Israeli individuals, because a European technology strategy that becomes associated with identity-based exclusion would undermine both the rule of law and Europe's ability to attract international scientific talent.

Key judgments

The central strategic risk for Italy and Europe is not immediate technological collapse but cumulative erosion of innovation optionality, because institutional disengagement reduces the density of relationships through which European companies and laboratories discover technologies, participate in early-stage development and acquire tacit knowledge, and such losses are difficult to identify until competitors have already captured the commercial opportunity.

The risk is amplified by the fact that the European Commission already identifies research fragmentation as a structural disadvantage relative to the United States in complex technologies including AI, biotechnology and quantum computing, making additional politically generated barriers difficult to reconcile with Europe's stated objective of closing the innovation gap.

Italy's situation is particularly contradictory because the state continues financing technology transfer, AI, HPC, quantum research and advanced scientific infrastructure while MAECI preserved bilateral scientific cooperation with Israel through 2026, even as several major universities introduced restrictive policies that can weaken exactly the international research connectivity those national investments are intended to exploit.

Germany has explicitly rejected the idea that scientific cooperation with Israeli researchers is an appropriate sanctioning instrument and has stated that it wants to deepen rather than damage scientific and economic cooperation with Israel, while France renewed the leadership architecture of its bilateral High Council for Science and Technology in 2026 and the United Kingdom continues to operate a structured science-and-technology partnership whose official roadmap attributes approximately £1.2 billion of UK economic impact to more than 250 partnerships facilitated by the UK–Israel Tech Hub.

The principal discriminatory-risk threshold is reached not when an Israeli entity is scrutinised more carefully because its activities create a documented legal or security concern, but when Israeli nationality, institutional location or absence of a prescribed political declaration becomes a substitute for evidence concerning the entity's own conduct.

Antisemitism must remain analytically distinct from criticism of Israel, but the deteriorating European environment cannot be ignored: the Commission reports unprecedented post-7 October levels of antisemitism since the EU's founding, while 2026 Eurobarometer data show that 73% of Italian respondents and 74% of French respondents considered antisemitism a problem in their countries, which creates a governance obligation to ensure that political pressure on Israel does not migrate into collective attribution against Jews or Israelis.

The balance of evidence supports a five-year outlook of selective fragmentation rather than comprehensive European decoupling, because national positions remain divergent, industrial requirements continue to sustain cooperation, and major states such as Germany, France and the United Kingdom continue to preserve or deepen scientific links even while other institutions introduce restrictions; the principal danger is therefore a progressively more expensive, politically conditioned and uneven relationship rather than a clean rupture.

The strategically superior European response is a combination of targeted accountability, rigorous dual-use screening, country-neutral ethical standards, continued researcher mobility, co-development, localisation and preservation of high-value scientific cooperation, because this framework allows Europe to uphold legal and foreign-policy principles without unnecessarily reducing its own technological options.

What would change the assessment

The present assessment would change materially toward a more severe decoupling scenario if the European Council approved broad restrictions excluding Israeli entities from major components of Horizon Europe, if Italy suspended the bilateral scientific agreement, if Germany reversed its explicit position protecting scientific cooperation, if France ceased operating the High Council for Science and Technology, if the United Kingdom terminated its bilateral science framework, or if major European industrial groups began systematically withdrawing from Israeli innovation networks rather than maintaining selected cooperation.

It would also strengthen if quantitative evidence showed a sustained fall in EU–Israel co-publications, patent collaboration, Horizon participation, researcher mobility and technology investment that could be traced to political restrictions rather than normal commercial cycles, because such evidence would demonstrate that institutional pressure had moved from declaratory politics into measurable innovation fragmentation.

Conversely, the assessment would weaken if universities increasingly adopted project-specific, country-neutral compliance frameworks instead of nationality-based restrictions, if Italian–Israeli joint laboratories funded through the 2026 MAECI process became operational, if Israeli participation in European research remained stable, and if anti-Israel political pressure remained concentrated on specific state policies rather than spreading into scientific and commercial relationships with institutions that had no demonstrated connection to the contested conduct.

Open official record

The most important remaining evidence gap is the absence of a harmonised European dataset quantifying cooperation lost specifically because of post-2023 political pressure, since official Horizon statistics reveal actual participation but not partnerships that were never proposed, abandoned during consortium formation or informally discouraged; resolving this gap would require project-level data from universities, research agencies and corporate R&D programmes showing applications, withdrawals, rejected agreements, mobility flows, co-publications, co-patents and investment relationships before and after the institutional-policy changes documented in Pillar I.

A second major gap concerns comparative treatment, because determining whether Israel is subjected to a uniquely restrictive institutional standard requires systematic evidence showing how the same universities and public bodies treat academic partners connected to other states involved in armed conflict, territorial occupation, severe human-rights allegations or extensive military research, and without that comparator no rigorous government report should simply assume either discrimination or equivalence.

A third gap concerns industrial substitution: Europe does not currently publish a comprehensive dataset showing whether cancelled or foregone Israeli technologies are replaced by domestic European solutions, American suppliers, Asian suppliers or no substitute at all, yet that distinction is essential because only the first outcome clearly strengthens European technological autonomy.

A fourth gap concerns human capital, particularly whether Israeli and Jewish researchers are changing destination choices because of the post-2023 political climate in European universities, since the mechanism is plausible and strategically important but requires mobility data rather than anecdotal inference.

A fifth gap concerns the long-term geographical redirection of Israeli innovation itself, because the Israel Innovation Authority already records greater R&D expansion abroad and warns about domestic R&D employment dynamics, but the destination of that expansion will determine whether Europe retains access to Israeli-origin technology or progressively cedes that access to the United States and Asian markets.

Final net assessment

Europe's relationship with Israel has entered a phase in which foreign policy, technological sovereignty, university autonomy, industrial competitiveness and identity politics can no longer be analysed separately, because actions taken in the name of one objective increasingly alter the conditions under which the others can be achieved, and the most important strategic error would be to assume that reducing scientific or technological engagement imposes costs only on Israel while leaving European competitiveness unaffected.

Israel is not so technologically indispensable that Europe would become incapable of innovating without it, and a serious report should reject such rhetoric because European technological power rests on a vastly larger aggregate economic and scientific base; however, the opposite proposition—that Israeli scientific and technological disengagement is essentially costless—is equally unsupported, because three decades of Horizon integration, extensive bilateral programmes, corporate technology partnerships and the concentration of Israeli capabilities in strategically important sectors demonstrate that Europe would be eliminating a genuine source of competition, diversification and technological discovery.

Italy confronts this contradiction more sharply than most European states because national policy continues to invest heavily in AI, quantum technology, HPC, technology transfer and international research while parts of the university system are constructing increasingly restrictive conditions for cooperation with a country that the Italian state itself has long treated as a priority innovation partner; if that contradiction is left unmanaged, Italy risks creating a system in which ministries invest public funds to strengthen technological sovereignty while autonomous institutions simultaneously narrow the international networks through which those investments can generate value.

The wider European response should therefore reject two symmetrical simplifications: Israeli institutions should not receive immunity from sanctions, export controls, human-rights scrutiny, procurement law or security review simply because they are technologically valuable, but neither should Israeli nationality become a substitute for demonstrating that an institution, company or individual has engaged in conduct justifying exclusion.

The correct dividing line is conduct, not collective attribution; dependency management, not technological isolation; co-development, not passive import dependence; and institutional accountability, not compelled ideological conformity.

If Europe maintains those distinctions, political disagreement with Israel can coexist with technological sovereignty and the protection of Jewish life.

If Europe abandons them, anti-Israel pressure will cease to be merely an external-policy instrument and increasingly become a mechanism through which Europe voluntarily fragments its own research system, narrows its technological options and exposes Israeli institutions—and eventually individuals—to political tests that are progressively more difficult to distinguish from differential treatment based on origin.

On the present evidence, that second trajectory is not inevitable, but the institutional mechanisms required to produce it already exist, which is why the next five years should be judged not by the intensity of political rhetoric surrounding Israel but by a more concrete set of indicators: whether bilateral laboratories continue to be created, whether universities preserve conduct-based rather than nationality-based screening, whether Horizon participation remains open, whether industrial partnerships continue producing joint intellectual property and manufacturing capability inside Europe, whether antisemitic hostility is prevented from entering professional and academic decision-making, and whether European institutions consistently apply to Israel the same evidentiary standards they claim to apply elsewhere.

Those indicators will determine whether Europe converts a difficult political relationship into disciplined strategic risk management, or instead turns the conflict over Israel into another source of the technological fragmentation that its own competitiveness strategy already identifies as one of Europe's most serious structural weaknesses.

---

Copyright of debuglies.com - Even partial reproduction of the contents is not permitted without prior authorization Reproduction reserved